Claim checker

Heat, such as that experienced in a sauna, causes temporary cellular damage, after which the cell produces repair proteins as a recovery response, including heat shock proteins. With repeated exposure, that response grows stronger and the cell becomes more resilient. Research in this area has not yet been tested on a large scale in randomised trials, but the mechanistic basis and the findings from reviews point clearly in this direction.

Walking around mealtimes does indeed help to limit blood sugar spikes, and several randomised studies confirm this. However, the claim reverses the comparison: according to the available research, short walking breaks spread throughout the day are actually slightly more effective than a single longer walk after a meal, not less so. Whether timing walks around mealtimes produces a 'much stronger' effect compared to spreading them across the day cannot be substantiated; the studies describe the direction of the effect, but draw no such emphatic conclusion about the size of the difference.

The claim states a precise duration of five to seven days, but the research does not support this. In humans, there is no clinically established threshold in hours or days for triggering autophagy, and multiple reviews suggest that even ordinary intermittent fasting may be too short to measurably increase autophagy. Moreover, autophagy in living humans is not yet well measurable: existing methods are indirect and lack the precision to confirm a "significantly measurable effect". A claim about five to seven days therefore cannot be substantiated.

A small pilot study provides preliminary indications that a fasting-mimicking diet may have cell-rejuvenating effects, including the restoration of certain cell types, but whether beta cells in the pancreas actually regenerate in people with type 1 diabetes has not yet been demonstrated in large, well-designed studies. The findings come largely from animal research, and the translation to humans has not yet been sufficiently established. The claim presents as settled fact what is, for now, a promising but unconfirmed hypothesis.

A fasting-mimicking diet improves several health markers, including weight, waist circumference, and inflammatory markers, as small randomised studies show. IGF-1 is typically included as an outcome in that research, but whether it actually decreases cannot be firmly established on the basis of the available evidence. The same applies to systolic blood pressure: the direction appears favourable, but the claim presents the combination of effects more categorically than the studies justify. In addition, several of the researchers involved have financial ties to the commercial product, which calls for caution when interpreting the findings.

Visceral fat is indeed more dangerous than subcutaneous fat: through direct pathways it disrupts the liver and other organs, and increases the risk of cardiovascular disease and diabetes, even in people with a normal weight. However, the phrase 'significantly more' in the claim goes further than what the research precisely indicates, as a concrete comparison of risk measures between the two fat types is not firmly established. The direction is correct, but the magnitude of the difference cannot simply be quantified.

Research actually shows the opposite: seed oils such as sunflower oil lower bad cholesterol and are associated with a lower risk of cardiovascular disease, especially compared to saturated fats. The claim that they raise blood pressure or cause disease is not supported by research in humans. The argument that seed oils promote inflammation, a commonly heard justification for this type of claim, also finds no support in the available research.

Intensive strength training measurably increases bone density in people with low bone mass, and high training intensity appears to yield the greatest benefit. The claim goes beyond the evidence on two points: that specifically 'impact' training makes the decisive difference cannot be substantiated, and that bone density of both the hip and the spine increases in postmenopausal women with osteopenia or osteoporosis has not yet been established in randomised studies. Furthermore, it has not been proven that strength training reduces the number of fractures.

Exercising more does reduce your risk of dying, and the benefit levels off beyond a certain amount, but the specific thresholds mentioned in the claim do not match what the research shows. The available evidence points to 450 to 750 minutes of moderate activity per week as the point at which further gains diminish, not the 300 to 600 minutes (5 to 10 hours) the claim suggests. The direction is correct, but the precise range of 2.5 to 5 hours of vigorous activity or 5 to 10 hours of moderate activity as the optimum for maximum risk reduction is not supported by the research.

There are tentative indications that meditation programmes can increase telomerase activity, and an effect on inflammatory markers through stress reduction is plausible. However, the step to specific biomarkers such as 8-oxodG and IL-6, after exactly twelve weeks of yoga combined with meditation, goes beyond what the available research supports. The studies showing positive signals are small and vary in design, and whether yoga as an addition makes a difference over meditation alone has not been demonstrated. The direction of the claim is not implausible, but the combination of specific biomarkers, a precise duration, and the pairing of yoga with meditation has not yet been convincingly tested.

Research does show that muscle strength declines significantly after middle age, but the findings specifically point to a loss of 3 to 4% per year in leg strength after the age of fifty, not 2 to 4% already from the age of forty. Furthermore, this refers to strength, whereas the claim speaks of muscle power, which is a subtly different concept. The direction of the claim is correct, but the starting age and the precise percentage differ from what the research shows.

A higher resting heart rate is indeed associated with an increased risk of death, and this relationship has been demonstrated independently of other risk factors. The direction of the claim is therefore correct. However, the precise figure of 15 to 20% per 10 beats per minute cannot be firmly established on the basis of available research: studies do show an elevated risk above certain thresholds, but a quantified linear relationship of this precision per increment of 10 beats has not been established. Moreover, research suggests that a very low resting heart rate in older age is not necessarily a good sign either, which makes the relationship less straightforward than the claim implies.

Research shows that the greatest health gains begin with even a modest amount of physical activity, so the direction of the claim is correct. However, the studies in our knowledge base use 150 minutes per week as the reference point for a significant reduction in mortality risk, not 75 minutes. Whether that halved amount is already sufficient for a measurable benefit on both premature death and cardiovascular disease cannot be firmly established based on the available evidence.

Research does indeed show that more physical activity lowers the risk of death, but that the gains diminish as you do more. That aligns with the direction of the claim. However, the specific ranges mentioned (2.5 to 4.5 hours, and more than 10 hours as risk-increasing) cannot be substantiated based on the available research: studies suggest the point at which benefits level off is closer to 450 to 750 minutes per week, and an increased mortality risk above 10 hours has not been demonstrated. That overtraining can be harmful is documented, but this applies to elite athletes who train extremely hard without adequate recovery, not to an increased mortality risk from recreational exercise of more than 10 hours per week.

Large cohort studies do indeed show that the greatest health gains in terms of step count occur roughly between 3,500 and 8,000 to 10,000 steps per day, and that more steps are associated with a lower risk of death. However, a halving of the risk at 8,000 compared to 4,000 steps is a far more precise claim than the research supports: the available studies show consistent associations, not exact risk ratios at those specific numbers. Moreover, this is observational research, so it has not been proven that the difference is actually caused by those extra steps.

That regular exercise reduces the risk of premature death is well established: going from no activity to 150 minutes of moderate exercise per week is associated with a 31% lower risk of dying early. But that finding is a long way from the claim that jogging extends life expectancy by five to six years. That specific figure cannot be supported by the available research, and reducing the risk of death is not the same as a concrete measure of life expectancy in years. So the claim asks more of the evidence than it can deliver.

Getting more exercise reduces your risk of dying early, and the biggest gains come from even modest amounts of physical activity. Research shows that 150 minutes of moderate exercise per week reduces the risk of premature death by 31% compared to being inactive. The claim that walking 15 minutes a day extends life expectancy by an average of three years goes beyond what this research actually establishes: that precise figure cannot be supported by the available evidence. So the direction is correct, but the specific numbers do not hold up.

Walking does indeed reduce the risk of premature death, but the direction and the figure in the claim are not quite right. Research shows that the step from no activity to 150 minutes of moderate exercise per week reduces the risk of death by around 31%, with the benefit levelling off beyond that point. Fifteen minutes a day amounts to just under 105 minutes per week, which falls below the 150-minute threshold and therefore yields a smaller benefit than 31%, though it still represents a meaningful gain. The claim that the reduction is specifically 15% for exactly 15 minutes a day cannot be substantiated on the basis of the available research.

Exercise demonstrably reduces the risk of premature death, and the direction of the claim is correct. The figure of 31% found in the research applies specifically to the step from no activity at all to 150 minutes of moderate exercise per week. The claim uses 'approximately 30%' as a single fixed value for all active people, but the actual benefit varies: more exercise provides some additional gain, though this levels off thereafter. 'Physically active adults' is therefore too broad a category to attach to a single figure.

That eating a lot of red meat can be harmful to your health is supported by robust research: large studies consistently show an increased risk of colorectal cancer and cardiovascular disease. However, the claim that red meat 'stimulates ageing processes' goes beyond what the available evidence demonstrates; the research focuses on disease risks, not on ageing as such. The claim about TMAO production does not appear in the evidence examined and therefore cannot be substantiated on the basis of what is currently known.

Olive oil, and extra-virgin olive oil in particular, contains polyphenols, and the evidence that it is good for cardiovascular health is fairly solid. However, the leap to autophagy is too large: it has not been demonstrated that olive oil specifically stimulates autophagy in humans, and the best-supported ways to maintain autophagy are fasting, exercise and adequate sleep. As for the effect on the gut microbiome, high-fat diets can actually disrupt that microbiome, while the evidence for an isolated effect of olive oil's polyphenols on gut bacteria remains preliminary and weak. The claim combines two assertions that each suggest more certainty than the research justifies.

Research points to multiple biological processes that together contribute to the development of cancer: the accumulation of DNA damage, a weakened immune system, and chronic inflammation are all well established. The immune system certainly plays a role, but research does not identify it as one of two key players. The "detoxification system" as a distinct key organ system in cancer development is not named or substantiated as such in the available evidence. The claim suggests a neat two-part division that research does not support.

The claim asserts a causal link between unprocessed emotions and damage to the colon and the immune system. Research does show that the gut and the immune system are closely connected, and that disruptions to the gut barrier or gut microbiome can dysregulate the immune system. However, there is no evidence that holding on to past emotions triggers that process. The leap from psychological emotions to concrete intestinal damage has not been demonstrated and goes far beyond what available research shows.

Emotional trauma and psychological stress can contribute to hormonal dysregulation through the cortisol system, but the evidence for this is limited to specific subgroups and far from strong enough to speak of one of the biggest causes. For digestive problems, available research does not address this link. When it comes to cancer, research points to physical factors such as obesity and physical inactivity as well-established risk factors, not emotional baggage. The claim presents trauma as a primary cause of three serious conditions simultaneously, and that has not been demonstrated.

Several large analyses found an increased risk of heart attack and cardiovascular disease associated with the use of calcium supplements, which supports the direction of the claim. However, the most recent large analysis from 2023 found no significant association, leaving the conclusion uncertain. Moreover, the research focuses on cardiac risk in a broad sense, not specifically on people who already have an elevated risk of atherosclerosis or coronary calcification; that level of precision goes beyond what the available evidence can firmly establish.

Research does indeed show that the pace of ageing varies considerably between individuals and that lifestyle, income and biological factors account for a large part of that variation. Excess weight, smoking and an unhealthy metabolic profile demonstrably accelerate the biological clock, and metabolism only declines noticeably after the age of sixty, not automatically before then. This lends support to the idea that much of the decline is not inevitable. However, the claim goes further than the evidence supports: research shows that many health problems can be influenced, but not that they are not a natural consequence of ageing. The distinction between what is modifiable and what is inherent to ageing has not yet been settled by science.

Research provides solid support for the claim that eliminating industrial trans fats prevents heart attacks and deaths: trans fats worsen the cholesterol profile, raise inflammatory markers and substantially increase the risk of a heart attack, even at low intake levels. The policy of removing them from the food supply is therefore considered well-founded. However, the specific figures of more than 10,000 heart attacks and thousands of deaths per year cannot be firmly established on the basis of available research, and will depend heavily on the country and population being discussed.

There is mechanistic evidence suggesting that caffeine can activate a cellular clean-up process, but the translation to everyday coffee consumption in healthy people has not yet been made. The specific time window of one to four hours is not supported by the research: no established threshold or timeline for coffee-induced autophagy in humans has been determined. The claim sounds more concrete than the evidence allows.

Creatine combined with resistance training demonstrably improves muscle strength in older adults, and the initial findings in postmenopausal women are promising. However, the claim goes slightly beyond what the evidence supports: for this specific group, large long-term studies are lacking, and the effects on body composition and broader physical performance have not been established firmly enough to speak of a proven combined effect. The direction is right, but the evidence is currently too limited to support the claim in its entirety.

Research in humans shows that muscle strength declines by around 3 to 4% per year after the age of fifty. A loss of 8 to 10% per year is considerably higher than that and is not supported by the available evidence. The claim also refers to 'muscle power' (explosive power), which is a slightly different concept from muscle strength, but for this concept too there is no substantiation for such a high percentage. The direction is correct, the percentage is not.

Eating fibre has demonstrable benefits for blood sugar regulation, blood pressure and gut health, and the link with cardiovascular disease and diabetes is biologically well supported. However, whether a high fibre intake significantly reduces all of these conditions goes beyond what the available evidence firmly establishes for each outcome: the effects vary by fibre type, by individual and by condition. Combining all these outcomes into one confident statement implies a degree of certainty that the research does not yet fully provide.

There are preliminary indications that ground flaxseed benefits bowel function, but human studies with constipation as a direct outcome are scarce. The effects on blood pressure and blood lipids in people with diabetes are the best supported by the available research. However, the claim adds weight loss, fasting blood sugar and HbA1c as established benefits, while the evidence for these outcomes in this population is not yet strong enough to be so categorical. The direction of the claims sounds plausible, but presenting all these outcomes together as proven goes beyond what current research allows.

Water-soluble fibres, of which psyllium is one, lower post-meal blood sugar and improve long-term blood sugar regulation in people with diabetes. This effect has been demonstrated in humans on multiple occasions. However, fibre supplements specifically are less well studied and the trials are too small in scale to draw firm conclusions at this point. The step from 'dietary fibre helps' to 'psyllium as a supplement improves both fasting blood sugar and HbA1c' is therefore larger than the available evidence supports.

That gene therapy aimed at telomere lengthening works in principle has been demonstrated in cell and animal studies: telomerase can compensate for telomere shortening and thus keep telomeres longer. In humans, however, clinical evidence is largely lacking, and there is a serious safety risk: the same mechanism that allows cells to survive longer can also fuel cancer cells. The claim is therefore correct in terms of what is biologically possible, but it overlooks the fact that 'actually lengthening telomeres in the human body' has not yet been properly proven outside the laboratory.

That nuts reduce the risk of cardiovascular disease is well supported by multiple large meta-analyses and a substantial study. However, the figure of 30% risk reduction cannot be substantiated on the basis of the available research. Moreover, the evidence says something about nuts as part of a varied diet, not specifically about replacing processed snacks with nuts as a standalone strategy.

The link between severe gum disease and a higher risk of cardiovascular disease has been demonstrated to be statistically robust. There is also consistent evidence from multiple studies, including a meta-analysis, for the connection with dementia, specifically via oral bacteria such as P. gingivalis. That said, the claim goes slightly further than the evidence allows: in humans, a causal relationship has not yet been established for either link, and a gingipain inhibitor that worked in mice had no effect on cognition in humans. The direction is correct, and the phrasing "associated with" honestly leaves the question of causality open, though it lacks the nuance that the evidence for the dementia link is weaker and less well established than that for cardiovascular disease.

Several large randomised trials do indeed show a modest memory benefit from a daily multivitamin in older adults, and the figure of 'two years' falls within the range reported by the research (two to three years less decline). However, the claim is worded too broadly: the effect appears to occur mainly in people at risk of nutritional deficiencies or with a history of heart disease, not in well-nourished older adults in general. Moreover, the positive findings come largely from a single research programme, and independent confirmation is still needed before this can be presented as established fact.

Lowering blood pressure demonstrably reduces the risk of strokes and cardiovascular events, and untreated high blood pressure in middle age clearly increases the likelihood of dementia later in life. However, the claim that a reduction of around ten points in systolic blood pressure leads to a substantial decrease in dementia risk cannot be firmly established on the basis of available research. The direction is plausible, the causal evidence specific to dementia is not yet watertight, and linking a precise figure such as ten points to an effect on dementia goes beyond what the studies show.

Research shows that muscle loss is indeed a risk with aging, but exercise does genuinely help to counter it. Regular strength training, combined with adequate protein intake, is the best-supported approach to preventing muscle loss, even at an older age. The claim that muscle breakdown accelerates regardless of training efforts is therefore incorrect: training makes a demonstrable difference. Specific evidence on perimenopause as a distinct phase in relation to muscle breakdown is lacking in the available research.

Declining estrogen levels during perimenopause do indeed promote the accumulation of visceral abdominal fat. Observational and mechanistic research shows that hormones and abdominal fat reinforce each other's effects: lower estrogen promotes fat deposits around the abdomen, and that abdominal fat in turn further disrupts metabolism. The relationship is reasonably well supported, although large controlled trials that conclusively prove causality are lacking.

The claim that weight loss is accompanied by bone loss is well supported: losing weight later in life almost always leads to some bone loss, even in physically active people. Whether GLP-1 medications specifically cause bone loss in the hip and lumbar spine in the absence of exercise cannot be firmly established based on the available research. Strength training substantially limits bone loss during weight loss, but does not prevent it entirely, so the claim that exercise fully prevents bone loss during GLP-1 use goes beyond what the evidence supports.

Mitochondria play a role in ageing, and there is evidence that mitochondrial mutations contribute to accelerated ageing, but the step to 'improved mitochondrial function reduces overall mortality and slows ageing' has not been demonstrated in humans. Exercise can improve mitochondrial health, but whether that translates into a longer lifespan in humans remains an open question. The claim presents as established fact what research regards, at most, as a plausible mechanism.

Exercise demonstrably increases testosterone in older men, and losing weight improves various health markers from as little as a modest 5 to 10% weight loss. The idea that weight loss also improves testosterone levels is in line with this broader pattern, but for erectile function specifically, the available studies offer no direct support. The claim combines two effects that are each plausible on their own, but for erectile function the link with weight loss has not been demonstrated on the basis of the available evidence.

Research shows that muscle strength remains fairly stable for up to around four weeks after stopping training, while endurance already measurably declines after ten days. The claim reverses these two: 'visible muscle loss after ten days' does not hold up well against the available evidence. Ten days is more the threshold for fitness loss than for muscle loss. The broader point, that stopping training sooner or later leads to loss, is correct.

Several randomised studies and meta-analyses show that short walking breaks after meals limit blood sugar spikes more effectively than a single longer walk afterwards. The claim is therefore correct in its general direction: spreading physical activity throughout the day beats doing it all in one continuous block. However, the claim goes further than the evidence supports: the walking breaks studied are typically much shorter than 15 minutes and are taken more than three times a day, and the comparison with exactly 45 minutes of continuous walking cannot be firmly established. Whether three 15-minute walks after each meal also outperform other ways of distributing those 45 minutes remains uncertain.

Multiple large observational analyses consistently show that a high intake of ultra-processed foods is associated with greater risks of type 2 diabetes, cardiovascular disease, obesity and premature death. These are precisely the chronic diseases and metabolic disturbances the claim refers to. Causality has not yet been conclusively established, but the associations are broad and robust enough to support the direction of the claim.

Chronically elevated cortisol does indeed have measurable effects on the brain and memory: prolonged stress impairs cognitive resilience, and the evidence for this comes from large review studies. However, the answers mention no direct link between chronically elevated cortisol and physical shrinkage of memory regions such as the hippocampus. Brain shrinkage in ageing is well documented, but in the available research it is attributed more to ageing and high blood pressure than specifically to cortisol levels. The direction of the claim is plausible, but the relationship between cortisol and measurable shrinkage of memory regions cannot be firmly established on the basis of this research.

A walk after a meal does indeed help to limit blood sugar spikes, and this is well supported by multiple randomised studies and meta-analyses. However, the claim compares walking after a meal with walking before a meal, and the available studies say nothing specific about that comparison. Moreover, research suggests that short walking breaks spread throughout the day are more effective than a single longer walk afterwards, so claiming that timing after versus before a meal makes 'significantly more' of a difference goes further than the evidence allows.

The research actually shows the opposite: with GLP-1 medications, roughly a quarter of total weight loss consists of lean mass, meaning muscle and other non-fatty tissue. The claim reverses this by asserting that the loss consists largely of intramuscular fat and liver fat rather than muscle mass itself. That distinction is not supported by the available research. Whether GLP-1 use specifically reduces intramuscular fat or liver fat, and in what proportion that contributes to total tissue loss, cannot be established on the basis of the available data.

The direction of the claim is correct: fermented foods demonstrably increase the diversity of the gut flora and lower inflammatory markers. However, that evidence comes primarily from small studies and certainly does not apply to every fermented product. Yoghurt and kefir have the strongest support, while products such as kimchi and kombucha have not yet been shown in humans to produce the same effect. The claim gives the impression that this is established for fermented foods in general, which goes beyond what the research currently shows.

Animal and laboratory research does indeed show promising results for taurine and ageing, and a lifespan extension in mice fits that picture. However, that precise figure of 10 to 12 percent does not appear in the available research we were able to assess, and in humans the effect on ageing has not yet been demonstrated. Clinical trials in humans are under way but have not yet produced published results, so the leap from mouse data to a concrete claim for humans is too large.

Research shows that roughly a quarter of the weight lost with GLP-1 medications consists of muscle and other lean tissue, and that this is a consistent pattern. The lower end of the stated range (25 percent) therefore aligns with that finding, but the upper figure of 40 percent cannot be substantiated based on the available evidence. Moreover, the loss does not consist exclusively of muscle mass: other lean tissue is also included. The general direction of the claim is correct, but the precise range and the description as purely "muscle mass" go beyond what the research shows.

Exercise, including intensive training, demonstrably raises growth hormone and other anabolic hormones in older adults, although the extent varies considerably from person to person. The leap to fat burning and the slowing of ageing goes beyond what the available evidence can firmly support: for those specific chains of effects, there is no conclusive proof in humans, and the only approaches with solid backing in humans remain exercise in general, adequate protein intake and avoiding overeating. The claim therefore contains a kernel of truth, but presents a series of effects as established fact when the research is too limited or too inconsistent to justify that.

Large cohort studies do indeed show that the risk of death drops noticeably as you take more steps each day, and the research supports around 7,000 steps as a beneficial target. However, the specific figure of a 47% lower mortality risk compared to 2,000 steps cannot be firmly established on the basis of the available evidence. Moreover, these are observational associations, not demonstrated cause and effect: more active people may lead healthier lives in a number of other ways, which makes a precise percentage claim vulnerable to criticism.

Large observational studies consistently show that abdominal fat strongly increases the risk of premature death, even in people with a normal weight and no other measurable metabolic problems. The direction of the claim is therefore correct. However, the specific figure of 'an almost twice as high risk of dying' cannot be firmly established based on the available research, and moreover these are observational associations in which cause and effect have not been fully proven.

The Mediterranean diet does indeed have the strongest and most consistent evidence of all diets when it comes to longevity, cardiovascular disease and cognitive health. However, claiming it produces "the best outcomes in terms of general and metabolic health" goes beyond what the research actually demonstrates: the evidence centres on cardiovascular disease, mortality and brain health, and comes largely from observational studies in which cause and effect cannot be fully separated. The claim also gives the impression that this diet wins on every health front, whereas for specific outcomes such as metabolic health the comparison with other dietary patterns has been less thoroughly investigated.

Multiple responses indicate that LDL plays a role in cardiovascular risk, but the full picture -- including triglycerides, HDL and lipoprotein(a) -- determines that risk. The claim points in the right direction: elevated LDL is associated with a higher risk of cardiovascular disease. However, it goes slightly too far by singling out LDL alone, because other lipid factors each play an independent role. Moreover, the claim makes no distinction between mildly and substantially elevated LDL, whereas the overall risk profile is what determines how concerning a particular value actually is.

Eating more fibre is indeed associated with better blood sugar regulation and insulin sensitivity, and a diet high in fibre is one of the best-supported ways to address insulin resistance. However, the threshold of 30 grams is hard to pin down: research points to 25 to 29 grams as a well-supported target, and not every type of fibre works equally well. Moreover, the claim overlooks the fact that other factors, such as physical activity and the rest of one's diet, also play a major role in preventing insulin resistance.

Vitamin D production through sunlight in summer is real and beneficial for bone health, but the link with bones is more nuanced than the claim suggests. Research shows that vitamin D alone does not demonstrably prevent bone fractures; only in combination with calcium is there a measurable effect, and even then primarily in older people at increased risk. Moreover, whether twenty minutes with bare forearms is enough for a 'significant' boost depends on factors such as skin type, latitude and time of day, and that nuance is absent from the claim.

Weight-bearing and dynamic exercise such as running and strength training does demonstrably stimulate bone formation, and the biological explanation for this is reasonably well established. The second part of the claim goes beyond what the available research supports: a direct comparison between swimming and running is lacking, so saying there is "no effect" is a stronger statement than the current science warrants. What is known is that activities without impact loading, such as swimming and cycling, stimulate the bones less or not at all, and that intensive cycling has even been linked to lower bone density.

A slightly higher body weight can stimulate bone density through mechanical loading, but the relationship is far from as straightforward as this claim suggests. A large amount of abdominal fat and a high fat-to-weight ratio are actually linked to lower bone density and a higher risk of osteoporosis. The role of oestrogen production in fatty tissue and the cushioning effect during a fall are not confirmed by research as well-supported protective mechanisms, and the location and composition of the fat largely determine whether or not the skeleton benefits.

Excessive alcohol use demonstrably harms your bones, that much is true. However, the idea that drinking in moderation is better than abstaining altogether is not supported by the available research. Large studies consistently show that less alcohol leads to better health outcomes, and international health organizations do not recognize a safe lower threshold. The claim implies a J-shaped curve in which moderate drinkers fare best, but that pattern has not been demonstrated specifically for bone health in the existing evidence.

The part about cortisol is solidly substantiated: prolonged elevated cortisol levels, as seen with corticosteroid use, impair bone formation through several simultaneous mechanisms, and this has been well documented for decades. For chronic low-grade inflammation as an independent driver of bone resorption, the available research provides no direct support, even though it is plausible that the mechanism works in the same direction. The claim thus combines two processes that each carry a different level of evidence, making the formulation go further than what can be firmly established.

Bone loss begins around the age of thirty, which aligns with the broader picture that peak bone mass is reached around that age, after which the balance between formation and resorption shifts. Research describes this as a well-established and widely documented biological process. The claim that bone mass can also stabilise after that age is correct: with intensive strength training, some bone formation or maintenance in adulthood is still possible, although the effect diminishes with age and in older people it is more often a matter of slowing down loss than of genuine growth.

It is well established that a hip fracture significantly increases the risk of death: in the first year after the fracture, the mortality risk is nearly three times higher than in peers without a fracture, and that elevated risk persists for years afterwards. The claim that 'about one third' die within a given period is not implausible in that direction, but that precise figure cannot be substantiated on the basis of the available research. Moreover, the risk varies considerably from person to person: men, people with dementia and people with multiple chronic conditions face considerably greater danger than others.

For each of these substances there is research suggesting a link with mitochondrial health, but the strength of the evidence varies considerably between substances and is far from convincing in humans in many cases. Urolithin A has a plausible mechanism of action through the clearance of damaged mitochondria, but the human studies are small, partly failed to reach their primary endpoints and largely come from the manufacturer. NAD+ supplements measurably raise NAD+ levels, but whether this actually leads to better mitochondrial health in humans has not yet been demonstrated. CoQ10 has the strongest human evidence, but specifically in people with heart failure, not as a general mitochondrial supplement. For PQQ, the available data are insufficient to reach a verdict. The claim that all these substances 'support' mitochondrial health therefore goes beyond what the current evidence justifies.

For people with existing cardiovascular disease or kidney problems, GLP-1 medications are well supported by evidence, but the claim that they promote a longer lifespan and protect against Alzheimer's is not yet backed up conclusively. The signals regarding brain protection and the prevention of dementia are promising, but have not been confirmed in randomised trials. The claim presents something as an established fact, while research in healthy individuals on this point is not yet complete. Moreover, the available research says little specifically about low doses as a distinct category.

Testosterone therapy has been studied for specific outcomes in people with an established deficiency, and the results are mixed: there is evidence of benefits in terms of body composition, libido and mood, but also real risks of atrial fibrillation, pulmonary embolism and kidney failure. A broader protective effect on all-cause mortality, in both men and women, has not been demonstrated in the available studies. The claim therefore goes considerably further than what the research has shown so far.

The decline of NAD+ with age and the role of chronic inflammation in this have been consistently established in both humans and animals. An important mechanism is indeed the increase of pro-inflammatory cells that actively break down NAD+. The claim attributes this specifically to the enzyme CD38, but that specific mechanism is not elaborated on by name in the available research. The general direction is correct, but that precise detail cannot be substantiated on the basis of current evidence in humans.

Research shows that both processes play a role in the age-related decline of NAD+. Increased breakdown by pro-inflammatory cells is indeed an important mechanism, but production also decreases, partly because proteins that counteract cellular aging become less active. The claim that reduced production plays no role goes beyond what the research supports.

The causal link between alcohol and cancer has been established for several types of cancer, including breast cancer, and applies even at low daily amounts. There is no proven safe threshold: even at one drink per day, there is a measurably higher risk of cancers including breast and colorectal cancer. The claim reflects this correctly.

Research shows that an intensive lifestyle programme is more effective than metformin in the short term, particularly for weight loss in people at increased risk of type 2 diabetes. In the long term, however, the difference is less clear: weight loss with metformin actually proves more stable. The claim therefore holds for the short term, but goes too far when applied to all time horizons and all outcome measures.

There is a connection between muscle health and brain health, but the link is less direct than the claim suggests. Weak muscles are associated with cognitive decline, and exercise demonstrably improves memory and planning skills. However, that relationship runs largely through physical exercise itself, not purely through the condition of your muscles: it is the act of training that benefits the brain, not simply having healthy muscles. A "direct link" between muscle health and brain health is therefore a stronger claim than the evidence justifies.

Even at an advanced age, including in your eighties and nineties, you can build muscle strength and muscle mass through strength training. The evidence for this is strong and consistent: muscle strength, mobility, and the ability to perform daily tasks independently all improve demonstrably, and even a low training volume already yields results. Two to three training days per week with progressive resistance is the best-supported approach, complemented by adequate protein intake.

Senescent cells accumulate inflammatory substances and thus form a source of chronic low-grade inflammation -- that mechanism is well documented. It is plausible that such local inflammation can also have systemic effects in the body, but the specific route via an ageing skin barrier has not yet been causally demonstrated in humans. The direction of the claim is therefore correct, but the emphasis on the skin as the starting point goes beyond what current research firmly establishes.

Muscle strength does indeed decline with age, but the figures in the research point in a different direction than the claim suggests. After the age of fifty, the loss amounts to around 3 to 4% per year, which over a decade is considerably more than the 10% mentioned. Whether that decline already begins at the same rate before the age of fifty cannot be firmly established on the basis of the available research. The direction of the claim is correct, but the percentage per decade that is cited underestimates how quickly the loss can occur.

Research does indeed show that it is not uncommon to have one organ that ages biologically faster than the rest of the body. Studies on brain aging indicate that 'nearly one in five people' has such an outlying organ, which aligns well with the claim. However, whether that figure applies specifically to Americans over the age of 50 cannot be established on the basis of available research: neither the age threshold nor the geographical scope appears in the studies. The direction of the claim is therefore correct, but its precision goes beyond what the evidence supports.

Declining oestrogen levels around menopause do indeed promote the build-up of abdominal fat and increase the risk of insulin resistance. Observational and mechanistic research supports this relationship fairly consistently: hormonal decline and the accumulation of abdominal fat reinforce each other in a cycle, with the abdominal fat in turn further disrupting metabolism. The evidence is largely based on observational research and large controlled trials are lacking, but the general direction of the claim is well supported.

A varied plant-based diet does indeed benefit the gut microbiome, but the evidence for the specific target of 30 different types per week is not well established. What research does show is that a broadly varied diet supports bacterial diversity, although an increased fibre intake only has a measurable effect in people who already have a diverse microbiome. In a controlled study, fermented foods even showed a stronger effect on diversity than a high-fibre diet. The general direction of the claim is correct, but the specific target of 30 is not supported by solid evidence.

Research in animals and small human studies suggests that fasting can activate stem cells and have cell-rejuvenating effects, which supports the general direction of this claim. However, the specific mechanism described -- namely that old immune cells are broken down and that stem cells subsequently produce demonstrably healthier new immune cells during refeeding -- has not been firmly established in humans through large, well-designed studies. The strongest evidence on the immune effects of fasting concerns reduced inflammatory markers and improved metabolic risk factors, not this precise regenerative process. The claim therefore describes a biologically plausible mechanism, but goes beyond what current evidence in humans supports.

Research does support the finding that a regular sleep schedule is associated with a lower risk of death, independent of total sleep duration: people with highly variable bedtimes and wake times face a higher risk of premature death, and that effect is indeed separate from how many hours they sleep. The claim that sleep regularity is a stronger predictor than sleep duration is therefore plausible, but the specific figures of 30 to 48 percent cannot be firmly established on the basis of the available research. Moreover, the evidence is at this point associative, meaning a causal relationship has not yet been demonstrated.

For muscular strength, the direction is correct: the greatest gains for health and survival come from building a basic level of strength, and resistance training is well supported as a means of reducing the risk of falls and premature death. For VO2 max, a higher value is also associated with longer life, without any clear ceiling being identified in the research. However, the claim that muscular strength specifically provides 'the majority of benefits' at a moderate level, while VO2 max continues to work up to 'very high levels', is a degree of precision that the available research does not support. Both associations have been demonstrated, but a direct comparison of the two curves is not substantiated.

Research shows that caloric restriction produces measurable metabolic benefits in humans, but there is no evidence that it slows the biological rate of ageing by a specific percentage. Available studies on epigenetic clocks and caloric restriction in humans are small and methodologically immature, which means those precise figures of 2 to 3 percent cannot be substantiated. The direction of the effect is biologically plausible, but genuine cellular rejuvenation and a quantified slowing of the ageing rate have not yet been demonstrated in humans through long-term research.

Visceral fat is linked to a clearly elevated risk of cardiovascular disease and heart failure in several large observational studies, so the direction of the claim is correct. The visceral adiposity index is a measure of that fat distribution pattern, but the claim goes beyond the available evidence by describing the risk as 'considerably elevated' and by listing stroke and cardiovascular mortality separately: that level of specificity cannot be substantiated by current research. Moreover, the evidence remains largely associative, meaning that causality has not yet been fully established.

Morning light does indeed help synchronize your biological clock: several lines of research show that daylight shortly after waking is associated with a better sleep-wake cycle, and the biological mechanism through melatonin suppression is well understood. The cortisol part is more subtle: research shows that sunlight can influence cortisol regulation, but that effect is less well quantified and depends heavily on the duration and intensity of exposure. The specific claim that this must happen within the first hour after waking cannot be firmly supported by the available evidence.

The claim that ultra-processed foods can harm bacterial diversity in the gut is supported by research: certain emulsifiers in heavily processed products measurably damaged the gut flora within two weeks. However, the available research says little that is concrete about increased intestinal permeability as a separate consequence, and chronic inflammation is implied in the studies but not elaborated as an independently demonstrated mechanism. The claim combines three effects as though they are equally well supported, whereas the evidence for microbial diversity is the strongest and the other two have not yet been tested in the same way.

Muscle strength, cardiovascular fitness and cognitive health are indeed associated with a lower risk of premature death and a longer period of healthy living, and the evidence for this is consistent across multiple large studies. However, the claim goes beyond what the research supports: it has not been demonstrated that the majority of longevity gains come from fitness and functional health rather than from disease prevention. That comparison between two strategies has not been made in the literature in that way, and the direction of causality remains unclear in many cases.

Research does indeed show that taking more steps each day goes hand in hand with a lower risk of premature death, and that this relationship is already visible with a modest increase. However, the specific figure of 12% lower overall mortality per 1,000 extra steps cannot be substantiated on the basis of the available research. Studies point to a general association between more steps and a lower risk of death, where the benefit is greatest for those who currently move very little and levels off as you already take more steps. One fixed percentage per 1,000 steps implies a precision that the science simply does not offer.

Intermittent fasting does indeed improve insulin sensitivity in most people, but the claim is incorrect on two points. First, the research concerns fasting that is generally aligned with the early part of the day and the circadian rhythm, not specifically a break in the middle of the day. Second, the concept of 'metabolic flexibility' is absent from the available evidence: the studies measure fasting insulin and insulin resistance, not the broader capacity to switch smoothly between burning fat and burning sugar. The claim is therefore too precise and partly points in the wrong direction.

The threshold of 20 grams of protein to preserve autophagy sounds precise, but that level of precision cannot be substantiated. Research shows that no established threshold values exist in humans for activating autophagy, nor for the role of protein intake in that process. Moreover, there is currently no reliable method to measure autophagy in humans, which means that boundaries of this kind cannot be verified in practice. The claim conveys a degree of certainty that the research does not support.

There are promising signals that GLP-1 receptor agonists may have beneficial effects on the brain, but a statistically significant reduction in dementia risk has not yet been demonstrated in randomised trials. The available evidence comes from early and small-scale research, and it is too soon to act on it. The direction of the claim is plausible, but the certainty implied by 'statistically significant' is not currently supported.

mTOR is indeed a central switch that drives cells to grow, and chronic overactivation contributes to ageing; autophagy, one of the body's protective mechanisms, also declines when mTOR is overactive. However, the research in our sources focuses on excessive mTOR activity in general, not specifically on animal protein or branched-chain amino acids as the culprit. Whether you can genuinely slow ageing by eating less animal protein has not yet been proven in humans; the best-supported ways to keep mTOR in check are eating less and exercising more.

The direction of the claim is correct: an unhealthy diet is associated with chronic inflammation, disruptions to the gut microbiome, and accelerated cellular ageing. This association has been demonstrated consistently across multiple studies, although the research is largely observational and mechanistic rather than establishing a firm chain of cause and effect. The available studies say little about blood sugar levels as a separate consequence of a poor diet, so that part of the claim is less well supported. The claim is therefore broadly accurate, but comes across as somewhat more definitive than the moderate evidence warrants.

The claim states that sirtuins, activated through exercise, fasting, or resveratrol, improve the functioning of mTOR and AMPK, but the research paints a different and more nuanced picture. Sirtuins may influence ageing processes in animal and laboratory studies, but convincing human data are entirely lacking. Moreover, exercise and fasting are themselves the direct activators of AMPK, while mTOR is actually suppressed by reduced food intake and exercise rather than "improved" via sirtuins. The proposed relationship, in which sirtuins act as an intermediary that upgrades the functioning of mTOR and AMPK, is not supported by the available research.

Metformin does indeed work through multiple interrelated mechanisms, including effects on cellular energy balance that are linked to AMPK. However, the picture is more nuanced than the claim suggests: at normal doses, disruptions in energy balance and inhibition of a specific liver enzyme play the greatest role, while the mitochondrial respiratory chain only appears to become relevant at higher concentrations. The claim that metformin improves insulin sensitivity is correct as a general direction, but the primary effect is the suppression of glucose production in the liver, not a direct improvement of insulin sensitivity as the main mechanism. Moreover, exactly how the various mechanisms interact has not yet been fully worked out.

Multiple human studies confirm that the gut flora changes with age and that a diverse flora is associated with healthier ageing. The first part of the claim, a decrease in diversity, is supported by observational research. The second part, a shift towards specifically pro-inflammatory bacterial species, goes a step further than the available evidence firmly establishes: the research is largely associative and shows rather a reduction in anti-inflammatory species than a proven increase in harmful ones. Furthermore, cause and effect have not yet been demonstrated.

The link between chronic low-grade inflammation and accelerated cellular ageing is well established and consistent with the research evidence. The association with diabetes and cardiovascular disease is also supported by multiple studies. For Alzheimer's disease, however, the connection is biologically plausible but causal evidence in humans has not yet been fully demonstrated. The claim is therefore largely correct, but presents the evidence for all three conditions as equally strong, whereas the evidence for dementia is less robust than it is for diabetes and heart disease.

The TRIIM protocol combines three substances for which the research is still limited. Growth hormone and DHEA have not been proven effective as anti-ageing treatments in healthy older adults, and the long-term safety of growth hormone is uncertain, including with regard to cancer risk. Metformin shows interesting signals from cell and animal research, but whether it genuinely slows ageing in people without diabetes remains an open question. The claim that this protocol replaces fat in the thymus with regenerated tissue and reduces epigenetic age goes beyond what current research into these three substances individually supports.

Multiple studies show that intermittent fasting improves insulin sensitivity and lowers fasting insulin levels, which supports the core of the claim. For blood pressure, the evidence is less direct in this context: studies point to broader cardiovascular benefits, but a specific effect on blood pressure independent of weight loss has not been firmly established. The crucial issue lies in calorie intake: a direct comparison between time-restricted eating and conventional calorie reduction is still lacking, so it has not been established that the effects occur without any change in what or how much you eat.

A walk after a meal does indeed lower the blood sugar peak, and this has been confirmed by multiple randomised studies and meta-analyses. Notably, however, short walking breaks of 2 to 3 minutes spread throughout the day appear to be more effective than a single uninterrupted walk afterwards. The claim implies that a 10-to-15-minute walk is the best approach, but the evidence points more towards frequent short breaks. In addition, little research has been conducted in healthy people with a normal body weight.

For both the growth hormone peak at 15 hours and the autophagy threshold at 17 hours, no clinically established time standard exists for humans. Research shows that fasting can mechanistically trigger autophagy, but several reviews note that even standard intermittent fasting may be too short to measurably increase autophagy. The precise time thresholds stated in the claim cannot be substantiated on the basis of the available evidence.

Animal studies do indeed show that fasting can stimulate stem cell production and has cell-rejuvenating effects, but in humans the evidence is limited to small pilot studies using biomarkers. The idea of a complete 'reset' of the immune system has not been firmly demonstrated: fasting does lower inflammatory markers and has indirect beneficial effects on the immune system through weight and blood sugar, but hard clinical outcomes such as fewer infections or remission of autoimmune diseases have not been sufficiently studied. The specific claim about 72 hours and its link to stem cell release goes beyond what current research in humans confirms.

Getting enough exercise does indeed largely protect you against the risks of prolonged sitting, but it goes too far to say that this risk is fully cancelled out. Research shows that meeting physical activity guidelines largely neutralises the risks of sitting, while other studies indicate that prolonged sitting harms the heart even in people who exercise regularly. Moreover, the specific figure of 60 to 75 minutes per day is not firmly supported by the available research, and the word "fully" goes beyond what the studies actually show.

That more daily steps go hand in hand with a lower risk of death is well established: the association begins at just a few thousand steps a day and is consistent across large international studies. However, the specific figure of 5,800 steps and the associated reduction of exactly 40% do not appear in any research we can confirm. What science does show is that the greatest health gains come from the shift from little activity to more, and that the benefit levels off somewhere between 6,000 and 10,000 steps depending on your age.

Intermittent fasting improves insulin sensitivity in most people, and this applies to the 5:2 variant with two fasting days per week as well. However, the evidence comes predominantly from small, short-term studies, which means the claim is somewhat more categorical than the research data justify. Moreover, a direct comparison with regular calorie restriction is lacking, so whether this approach works better than simply eating less has not yet been established. In older adults and people who exercise intensively, potential muscle mass loss may also deserve attention.

Animal and laboratory research shows that artificial sweeteners can affect blood sugar regulation, but small studies in healthy people do not consistently find this effect. For saccharin and sucralose specifically, the claim is stronger than the research justifies: the available studies contradict one another and there is no scientific consensus. The direction of the claim is therefore not without basis, but the phrase 'negatively affect' suggests more certainty than the current evidence supports.

Several large observational studies do indeed show that high consumption of ultra-processed food is linked to greater risks of cardiovascular disease, diabetes and depression. For cancer, the association is more specific than the claim suggests: the evidence points mainly to sugar-sweetened beverages and an increased risk of certain types of cancer, not cancer in general. Moreover, causality has not been conclusively established anywhere, and the risk depends strongly on the type of ultra-processed product and your overall diet.

The gut microbiome does indeed play a role in oestrogen metabolism, but the relationship works differently from what the claim suggests. Research shows that changes in the gut microbiome after menopause can further suppress already low oestrogen levels, rather than fermented foods making oestrogen more usable for the body's cells. Proven interventions targeting the gut microbiome in menopausal women do not yet exist, and the idea that fermented foods steer oestrogen breakdown in a way that benefits the user is not supported by the available research.

Combinations of strength and endurance training show the strongest results in improving blood sugar regulation in people with type 2 diabetes, and there are multiple indications that such a combined programme also most effectively improves insulin sensitivity. However, the word 'significantly' goes further than the available evidence justifies: how large the reduction in HbA1c actually is, and whether it is always clinically meaningful, depends strongly on a person's weight, diet and baseline situation. For people who are overweight, diet also plays a greater role than the type of training.

Resveratrol and other polyphenols do show protective effects in cell and animal studies, such as inhibiting oxidative damage and inflammation, which aligns with the idea of cellular repair. However, the concept of a 'hormetic effect' goes beyond what the available evidence supports in humans: the compound is poorly absorbed by the body, clinical trials in humans are scarce and have partly yielded negative results, and the effects on gut bacteria are promising but have not yet translated into concrete long-term health benefits. The claim therefore points in the right direction, but presents as established fact what has so far been demonstrated primarily in the laboratory.

Research makes it clear that healthy years and total lifespan are two measurably distinct things that do not automatically go hand in hand. For most interventions, from fasting to supplements, the primary goal is to improve healthspan, not to extend total lifespan. Even caloric restriction, the best-supported approach, has not yet been fully proven in humans to achieve both simultaneously. The claim assumes an automatic link that the evidence does not support.

Muscle strength does indeed play a well-supported role in healthy ageing: losing it increases the risk of falls, disability and premature death, and strength training demonstrably reduces those risks. Bone density is also considered relevant in the research, but the evidence for it is more limited and focuses mainly on slowing loss rather than building it up. The claim goes a step further by presenting muscle mass and bone density together as one of the most important indicators of both healthspan and longevity, whereas the evidence for bone density as an independent predictor of longevity is not stated that explicitly in the available studies.

Mitochondrial dysfunction and mutations are indeed closely linked to biological ageing, and that relationship is well established. However, the claim states that this is the cause of a 'natural death from old age', whereas research shows that ageing is driven by multiple interacting mechanisms, such as the accumulation of senescent cells and chronic inflammation. Mitochondrial exhaustion is a relevant factor, but the claim that it is the central cause of death from old age goes beyond what the available evidence supports.

Research shows that chronic stress causes measurable damage in brain regions important for memory, and that prolonged stress accelerates biological ageing through multiple mechanisms. The idea that stress can contribute to structural changes in the brain is biologically plausible and supported by animal studies. However, the word "shrink" goes a step further than what the evidence in humans can confirm with certainty: the effects on brain volume in humans have been demonstrated primarily through associations and have not yet been conclusively proven to be causal. The direction of the claim is therefore correct, but the phrasing is more categorical than the current evidence warrants.

Research shows that a diet rich in fermented foods can increase gut microbiome diversity and lower inflammatory markers, and there are randomised studies that support this. The direction of the claim is therefore correct, but the evidence comes mainly from smaller studies and does not apply equally to every fermented product. Moreover, the specific timeframe of eight weeks cannot be firmly established on the basis of available research, and the strongest results apply above all to kefir and yoghurt, not to all fermented foods without distinction.

For repeated antibiotic use, research shows that it disrupts the gut microbiota and can thereby impair immune function, but a proven causal link to broader immune-related conditions later in life has not yet been established. The available research contains nothing to support formula feeding and caesarean section as risk factors for immune-related conditions, so those two parts of the claim cannot be assessed. The direction is partially correct for antibiotics, but the claim presents all three factors more confidently and more broadly than the evidence justifies.

Research shows that combining exercise, mental stimulation and social engagement is associated with a lower risk of cognitive decline and dementia. The FINGER and POINTER studies demonstrate that such combined programmes have a measurable effect on brain health. However, the available research says nothing conclusive about racket sports specifically extending lifespan, and the contribution of the social component to brain health has not yet been isolated. The direction of the claim is therefore correct, but the level of certainty is lower than it suggests, and the link to longevity cannot be firmly established.

Research shows that walking after meals measurably reduces blood sugar spikes, and that effect is well supported by multiple randomised studies and meta-analyses. Whether walking also lowers HbA1c levels cannot be established on the basis of the available research into walking: the findings on HbA1c relate exclusively to medication, not to aerobic exercise. The claim therefore holds for fasting blood sugar and blood sugar response, but the link to HbA1c reduction through walking is not supported by the evidence.

That NAD+ declines with age has been consistently demonstrated in both humans and animals, and the mechanisms behind it are reasonably well understood. However, the research does not confirm the specific figure of 'about 50 percent around middle age': the direction of the claim is correct, but that precise percentage cannot be substantiated. The extent and rate of the decline can moreover vary from person to person and from tissue to tissue.

Research confirms that red light activates a mitochondrial protein and thereby triggers a chain of cellular processes, which makes the claims about mitochondrial activation and ATP production biologically plausible. However, this mechanism has been demonstrated mainly in laboratory and stem cell studies, not convincingly in living humans. The same applies to the claim that red light therapy reduces inflammation: there are positive signals, but solid clinical evidence in humans is largely lacking. The statement presents these three effects as established facts, while the evidence is still too limited to justify that.

Research shows that mild heat such as a sauna activates a biological protection system that strengthens cells and makes them more resilient, and this effect is well documented. Heat shock proteins (also known as chaperones) do indeed play a role in the folding and clearance of damaged proteins, and this mechanism fits with what is known about protein accumulation in ageing. Nevertheless, it has not yet been conclusively demonstrated in large long-term studies in humans that sauna use activates this system effectively enough to actually clear damaged proteins. The direction of the claim is biologically plausible, but it goes further than the current evidence in humans supports.

Research confirms that strength training is the cornerstone of regaining muscle mass later in life, and that adequate protein amplifies that effect. The combination of training and protein therefore does indeed work, even in older age. However, the claim goes further than the evidence justifies: the word 'significantly' cannot be substantiated, and the studies address muscle loss due to ageing or weight loss, not specifically recovery after serious illness and prolonged bed rest. Whether that particular situation responds in the same way to protein plus training has not been demonstrated.

It is correct that fasting stimulates autophagy: this has been robustly demonstrated in multiple organs and tissues, including in humans. Autophagy is indeed a cellular cleanup system that breaks down damaged proteins and other cellular components. However, the claim specifically mentions 'glycated proteins' as the target, and that distinction is not made in the research: autophagy clears a wide range of damaged cellular components, not selectively glycated proteins. That addition goes beyond what the evidence supports.

Glycation is a well-documented mechanism in which sugar binds to proteins and produces harmful waste products known as AGEs. Research confirms that AGEs cause damage to the eyes, among other tissues. The claim that this specifically leads to clouding of the eye lens (cataracts) points in the right direction, but the available evidence describes eye damage in broader terms and does not make the direct step to lens clouding explicit. The core of the claim is biologically plausible, but that precise mechanism as it applies specifically to the lens cannot be firmly established on the basis of current research.

Research consistently shows that eating more fibre is associated with a lower risk of colorectal cancer, and the evidence for this is strong. The claim therefore points in the right direction. However, it goes beyond what the evidence supports by specifying a threshold of 40 grams per day: that figure cannot be established on the basis of available research. Protection appears to increase with higher fibre intake, but a precise minimum amount at which the effect occurs has not been determined.

It is true that creatine plays a role in the energy metabolism of brain cells through the ATP system, and there are positive indications that it can relieve cognitive complaints during sleep deprivation. However, the effect has not been broadly proven: it is strongest in people with elevated fatigue, sleep deprivation, or a plant-based diet, and for healthy, well-rested people creatine appears to do little. The claim gives the impression that creatine improves cognition in everyone experiencing sleep deprivation or stress, while the research for this is still too limited and too inconsistent.

Not a single study has tested the cortisol cocktail -- also known as the adrenal cocktail -- as a product in humans. Moreover, the popular assumption behind it, that stress leads to a cortisol deficiency that can be replenished with such a drink, is incorrect: studies on chronic fatigue and stress actually show elevated cortisol levels. The claim that there is no scientific evidence for lowering cortisol levels through such a cocktail is therefore supported by the available research.

Research shows that soluble fiber lowers blood sugar after a meal, and that the overall composition of the meal plays a role in this. However, the claim that proteins and fiber together specifically prevent a blood sugar crash goes beyond what the available evidence demonstrates. The dampening of the spike is well supported for fiber, but the notion of a 'crash' as a consequence of a spike, and the specific combination with protein, are not confirmed in that way by the research.

Research confirms both parts of this claim. Sleep demonstrably strengthens memory: the brain processes and consolidates new information during sleep, and even a single night of too little sleep impairs that process. In addition, it is well documented that the glymphatic system, the brain's drainage network, is active during sleep and largely dormant during the day; deep sleep drives this waste-clearing process. Both functions together are broadly supported by multiple studies.

Research confirms that the glymphatic system, the brain's waste-drainage network, is active during sleep and that deep sleep plays the greatest role in this process. The claim that waste products and misfolded proteins are removed in this way is broadly correct. However, the description that neurons synchronously 'contract and expand' to achieve this is a specific mechanistic detail that the available research does not describe in those terms. The cleansing effect of deep sleep has been demonstrated, but the precise cellular mechanism behind this claim cannot be substantiated.

That synthetic clothing releases microplastics and that these particles enter the body through breathing and possibly through the skin is consistent with what research shows: microplastics have demonstrably been found in the human body. There is also research showing that some hormone-disrupting substances are present in everyday plastic products and are measurable in blood and fatty tissue. However, the claim states too categorically that polyester clothing acts as a hormone disruptor through these routes: the evidence for that specific mechanism in humans is still predominantly associative and comes largely from laboratory and animal studies. How significant the risk of clothing as a source is during everyday exposure, and whether it genuinely leads to hormonal disruption, has not yet been scientifically established.

Research shows that magnesium L-threonate (MgT) reaches the brain more effectively than common forms of magnesium, and that small human studies show cautiously positive effects on memory and cognition. The claim regarding crossing the blood-brain barrier is therefore supported. However, the specific mechanism mentioned in the claim, namely increasing synaptic plasticity in the hippocampus, comes from animal research and has not yet been convincingly demonstrated in humans. The evidence for such a categorical claim remains too limited.

There are positive indications that glycine in an amount of around 3 grams taken before bedtime can slightly improve sleep quality, and a plausible biological mechanism is known. However, the available evidence in humans is thin: the studies are small, and a significant portion of them comes from the manufacturer itself rather than from independent researchers. The claim that glycine can promote sleep is therefore correct in direction and dosage, but conveys more certainty than the research currently justifies.

Research shows that sleep deprivation reduces the response to vaccinations, which supports the core of the claim. The relationship has been demonstrated in multiple human studies and is considered likely causal. However, the claim states that sufficient sleep actively improves the antibody response, whereas the evidence mainly shows that too little sleep weakens it. Whether extra or optimal sleep around the time of vaccination also raises the response above its normal level cannot be established on the basis of the available research.

Research shows that sleep deprivation disrupts hormone balance after just a few nights and is associated with increased appetite and weight gain. The finding that sleep restriction raises hunger hormones fits within this broader picture. However, the specific combination of exactly 4.5 hours over four nights and an increase of around 350 kcal per day cannot be traced back to the available evidence, so that precise figure cannot be substantiated. The direction of the claim is correct, but the specific numbers cannot be confirmed.

Research shows that deep sleep and REM sleep each play their own role in memory consolidation: deep sleep anchors factual memory, while REM sleep integrates memories and subtly reshapes them. The two phases complement each other and are not interchangeable. The evidence for this comes largely from human studies, although causal proof remains incomplete in many areas. The claim that both phases are essential for memory consolidation aligns well with what current research shows.

Animal research on BPC-157 does consistently show positive signals in tissue healing, including tendons, ligaments and nerves. However, that evidence comes almost exclusively from animal studies: in humans, the research consists of a small case series and a pilot study with only two participants. Whether BPC-157 actually accelerates recovery in humans, and at what dose, has therefore not been established. The claim presents as fact what is, for now, only a promising but unproven hypothesis.

Research into retatrutide does indeed show impressive weight loss, but it amounts to around 22 percent of body weight, not one third (around 33 percent). The claim therefore considerably overstates the evidence. Moreover, these are early-stage clinical studies without direct comparisons to other treatments, and the long-term safety profile remains largely unknown.

Research shows that sunlight affects several hormones, such as vitamin D, beta-endorphin and melatonin, but the evidence on sunlight and hormones does not explicitly identify testosterone and oestrogen as hormones that are raised by UV exposure. The claim therefore goes beyond what the available evidence concretely confirms. A link may exist, but it cannot be firmly established on the basis of current research.

The claim that 15 grams of collagen provides approximately 3 grams of glycine is correct in terms of composition, and there are preliminary signals that glycine (around 3 grams before bed) may slightly improve sleep quality. However, the evidence for this is thin: it is based on small studies, a significant portion of which come from the manufacturer itself. The specific claim that this supports connective tissue recovery during sleep goes beyond what the available research can firmly establish.

Research shows that fresh broccoli sprouts are a rich source of sulforaphane and that many commercial supplements contain considerably less bioavailable sulforaphane, but the precise ratio of 'many times higher' cannot be substantiated on the basis of the available evidence. Moreover, it has not yet been established whether higher blood levels of sulforaphane in humans also lead to measurable health benefits. The direction of the claim is plausible, but the strong wording goes further than what current research demonstrates.

Research confirms that a drop in body temperature is necessary to fall asleep and stay asleep: if the body is unable to lower its temperature sufficiently, sleep is disrupted. However, the precise range of 1 to 3 degrees for both falling asleep and waking up cannot be found in the available research. The general direction of the claim is correct, but those specific figures cannot be substantiated.

Research into grounding has produced some initial positive signals, but the studies are very small and have not been independently replicated. The only controlled experiment had just sixteen participants, which is not enough to make firm claims about effects on cortisol. The direction may be correct, but the claim that grounding lowers cortisol levels is not yet adequately supported by sufficient evidence.

Research shows that physical activity, particularly in the morning, supports the biological clock and reinforces the day-night rhythm. Daylight and a consistent morning routine also help synchronise your clock, making it easier to fall asleep in the evening. However, the claim that morning exercise is a 'powerful' zeitgeber goes somewhat beyond what the current evidence can substantiate: the studies are predominantly observational and demonstrate an association, but the magnitude of the effect relative to other zeitgebers such as daylight has not been precisely established.

Research shows that morning light plays an important role in synchronising the biological clock and promoting daytime alertness. The evidence for this is consistent, although large controlled experiments in humans are still lacking. However, the claim goes further by labelling morning sunlight as 'the most powerful stimulus': that specific superlative cannot be substantiated on the basis of available research, and other factors such as a consistent sleep-wake schedule and limiting evening light also play a demonstrable role in regulating the circadian rhythm.

Research shows that REM sleep integrates memories while subtly reshaping them, which is consistent with the idea that emotional charge is processed. Nevertheless, the claim goes beyond the available evidence: the function of REM sleep is described as the integration and adjustment of memories, not explicitly as the complete removal of emotional charge. Moreover, much of this research has not established causality. The general direction is correct, but 'crucial for removing emotional charge' is stated more strongly than current science can firmly support.

Research shows that evening light suppresses melatonin production, and that morning light helps synchronise the biological clock. However, the claim reverses this: in the morning, melatonin levels are already naturally low, because melatonin is a nocturnal hormone. The suppression of melatonin by morning light is therefore a much smaller effect than in the evening, and the available evidence relates primarily to evening exposure. The direction is biologically plausible, but 'directly suppresses' implies a strong and well-established morning effect that research does not specifically describe in those terms.

It is correct that bright light in the morning suppresses melatonin production and that the suprachiasmatic nucleus (the biological clock) plays a central role in this. This mechanism is described as well understood. However, the claim states that morning light stops melatonin production, whereas the suprachiasmatic nucleus already sends an inhibitory signal to the pineal gland during the day regardless, and morning light strengthens and sharpens that signal. Furthermore, the claim specifically refers to stopping production, while research shows that what actually occurs is suppression and the fine-tuning of the biological clock, not a hard on-off switch.

Multiple reviews consistently show that 1.2 to 1.6 grams of protein per kilogram of body weight per day is well supported for maintaining muscle mass in people who do strength training. The claim is therefore correct in terms of the range. However, it goes somewhat beyond what the evidence shows: the studies support this amount primarily for maintaining muscle mass, and maximizing muscle growth is a stronger claim than what the research actually demonstrates. Moreover, protein alone is considerably less effective; the combination with strength training is a prerequisite that the claim does not mention.

Research does indeed show that ashwagandha can measurably lower cortisol levels, but the best available meta-analysis shows no consistent or convincing effect on how stressed people actually feel. The specific figure of 28 percent does not appear in the available research, and results vary across studies, doses, and populations. So while the direction is correct, that precise percentage cannot be substantiated based on the available evidence.

Research confirms that the brain cleans itself during sleep via the glymphatic system, and sleep is mentioned as one of the ways to keep autophagy active. The claim that autophagy processes are specifically activated during sleep to clear cellular waste is therefore broadly correct. However, the direct link between sleep and the activation of autophagy in cells is not well supported by the available evidence, and existing knowledge about sleep and the brain relates primarily to the glymphatic system, not to autophagy as such.

Research shows that chronically sleeping too little disrupts blood sugar regulation and increases the risk of type 2 diabetes in the long term. This effect occurs after just a few nights of insufficient sleep and works through several biological mechanisms. However, the claim that fewer than six hours of sleep causes an acute and significant rise in insulin levels goes beyond what the evidence firmly establishes: the studies demonstrate disrupted blood sugar regulation and an increased diabetes risk, but an acute, substantial insulin spike as a direct consequence is not confirmed that specifically.

Research does confirm that insulin and cortisol influence each other and other systems, but there is no evidence that normalizing these two hormones alone is sufficient to restore virtually all other hormones automatically. Chronically elevated cortisol affects multiple systems, including immune function, sleep and body composition, and recovery depends on more factors than cortisol and insulin levels alone. The claim suggests a direct and near-complete chain reaction that the available research does not support. The reality is more complex: hormonal balance is an interplay of many systems, each with its own regulatory mechanisms.

Population studies show positive associations between spermidine intake and less cognitive decline, but these are not demonstrated causal effects. Randomised trials in humans are still ongoing and largely incomplete, so the claim that a spermidine-rich diet improves cognitive scores in older adults with neurocognitive disorders goes beyond what the current evidence shows. The direction of the findings is cautiously positive, but a proven improvement in people with neurocognitive disorders has not yet been established.

Research confirms that autophagy is a genuine cellular cleanup and recycling system, and that spermidine is one of the best-supported candidates for activating this system. It is also correct that autophagy declines with ageing: this association has been demonstrated consistently across multiple animal species and is widely supported by review studies. The claim accurately summarises what the research shows, although definitive evidence in humans remains limited.

Large-scale population studies do indeed show a positive association between higher dietary spermidine intake and lower mortality, but these are observational studies that do not prove a causal relationship. The specific figure of approximately 30 percent lower mortality is not firmly established in the available research. Furthermore, the associations found apply to dietary patterns as a whole, so they cannot simply be attributed to spermidine alone.

Research shows that creatine can promote muscle recovery in older adults (60+) and may have positive effects on memory, particularly in combination with strength training. However, the evidence for a memory effect is strongest for people aged 66 and older, and the findings on muscle recovery are not entirely consistent. For attention specifically, the evidence is less clear: studies show cognitive benefits under conditions of fatigue or sleep deprivation, but not broadly for all older adults. The claim is largely correct, but is somewhat too categorical about both effects simultaneously.

The evidence that a high salt intake raises blood pressure and increases the risk of cardiovascular disease is solid and consistent. Nevertheless, the statement goes slightly further than the research justifies: restricting salt is most beneficial for people who already have elevated blood pressure or a genetic predisposition to it, and they are the ones who benefit most. Whether reducing salt can fully prevent high blood pressure in everyone is a stronger claim than what the evidence supports.

Research shows that gut bacteria ferment fibers and in doing so produce short-chain fatty acids such as butyrate. These substances support the gut lining and inhibit inflammatory processes. A consistent link is also visible between a disrupted gut lining and low-grade inflammation in the body. The claim aligns well with current knowledge, although the effects on the immune system are not equally predictable for everyone and large randomised trials in humans are lacking for some of the details.

Our answer on fibre intake confirms that a daily intake of 25 to 29 grams of fibre is associated with a 15 to 30% lower risk of premature death, which supports the direction of the claim. However, the claim differs on one point: the upper limit stated is 30 grams, whereas our answer cites 29 grams as the amount studied. In addition, the research concerns an association, not a proven causal effect, so the phrasing 'reduces total mortality' is more definitive than the evidence allows.

There is plausible evidence that too little sunlight is associated with a higher risk of cardiovascular disease, but a proven causal relationship has yet to be established. The claim that exposure to bright daylight reduces the risk of dying from cardiovascular disease and metabolic disorders goes beyond what research can currently support. Moreover, the available evidence focuses on the harmful effects of too little sunlight, not specifically on 'bright' daylight or on mortality from metabolic disorders. The direction is plausible, but the claim is more definitive than the evidence warrants.

The only controlled human study shows that GlyNAC does indeed have positive effects on glutathione levels and oxidative stress. However, the claim goes beyond the evidence by stating that those levels are restored 'to the levels of young people', given that the study included only 24 participants over 16 weeks. That is too small and too short to justify such a far-reaching conclusion. The direction is correct, but the claim is more definitive than the available research supports.

Research does indeed show that more daily steps are associated with a lower risk of death, and that the greatest health benefits occur roughly between 3,500 and 10,000 steps per day. The general direction of the claim is therefore correct. However, the specific figures of a 47% reduction in overall mortality and a 14% reduction in the risk of type 2 diabetes at exactly 7,000 steps compared to 2,000 steps cannot be substantiated on the basis of the available research. Furthermore, these are associations from observational studies, not proven cause and effect.

Urolithin A does indeed have a plausible mechanism of action through the clearance of damaged mitochondria, a process called mitophagy. The claim is therefore correct in its general direction. However, the assertion that damaged mitochondria are 'recycled into healthier mitochondria' is somewhat too categorical: mitophagy breaks down damaged mitochondria so that new ones can be produced, but those new mitochondria are not recycled versions of the old ones. Moreover, this mechanism has not yet been firmly established in humans, and the existing research comes largely from the manufacturer itself.

Research shows that fasting can stimulate autophagy, but no established threshold in hours has been identified for humans. Several reviews even suggest that ordinary intermittent fasting may be too brief to measurably increase autophagy. Added to this, autophagy is difficult to measure reliably in living humans: the available methods are indirect and capture only a snapshot. The claim that sixteen hours of fasting demonstrably upregulates autophagy markers in humans goes beyond what current evidence supports.

There are encouraging indications that vitamin K2 may improve bone mineral density in postmenopausal women, particularly in combination with vitamin D. However, the results are not fully consistent and the evidence is not strong enough for a broad recommendation. The claim presents the effect as established, whereas the studies describe it as promising but variable.

Research into hydrolysed collagen peptides (5 g/day) shows positive but limited results for bone density in postmenopausal women. An important caveat is that a considerable share of this evidence comes from industry-funded studies, which limits its reliability. The direction of the claim is correct, but the statement is more definitive than the available research justifies.

Research shows that fasting can stimulate autophagy, but there is no clinically established threshold in hours after which this process begins in humans. Several reviews indicate that even common intermittent fasting may be too short to measurably increase autophagy. The claim that 16 hours is the threshold is therefore not supported by scientific evidence in humans.

Research shows that regular alcohol consumption chronically raises cortisol levels, which supports the core of the claim. The available evidence says nothing concrete about inflammation. The phrasing that alcohol does not physiologically reduce stress is accurate in the sense that alcohol actually drives stress hormones up rather than suppressing them, but the claim implies this is the full picture, while the inflammatory aspect is not supported by the evidence cited here.

Large and consistent research shows that seven to eight hours per night is the healthiest range for adults, and that structurally sleeping fewer than seven hours is associated with more illness and a higher risk of mortality. The claim that sleeping fewer than seven hours is unhealthy therefore aligns well with the evidence. However, the upper threshold of ten hours cannot be firmly established: the research points to increased risks with very long sleep durations, but does not identify ten hours as a specific tipping point. The claim that seven to nine hours represents a universal biological need also goes somewhat beyond the evidence, as individual sleep requirements can vary.

Smoking demonstrably accelerates skin ageing through oxidative stress and inflammation, and multiple systematic reviews confirm that smoking is an independent risk factor for wrinkles and loss of elasticity. However, the claim goes beyond what the research shows: there is no evidence that nicotine specifically causes dehydration as a mechanism behind skin ageing, and the claim focuses on nicotine in particular while the evidence concerns smoking as a whole. Moreover, evidence for the role of dehydration in this context cannot be found in the available research.

Population research offers tentative indications that low doses of lithium, such as those found in drinking water, are associated with less cognitive decline and possibly beneficial health effects. However, the claim that higher lithium levels correlate with lower all-cause mortality goes beyond what the available research can confirm with certainty: the results are mixed and the studies are preliminary in nature. There is no strong evidence that this association holds for the broad category of all causes of death.

Large population studies consistently show that chronically sleeping too little is associated with a higher risk of death and serious conditions such as heart disease and stroke. The claim is therefore correct regarding short sleep, but the evidence for long sleep as an independent risk factor for higher mortality is only touched on briefly in the available research. Furthermore, the evidence is based on observations rather than experiments, meaning a causal relationship has not been established. The direction of the claim is plausible, but the symmetry between too little and too much sleep is less well supported than the claim suggests.

Most large studies show that a nocturnal blood pressure dip is absent in some people, and that this is associated with a considerably higher risk of heart attack, stroke, or heart failure. That association is stronger than the one seen with a high daytime reading at the doctor's office. The research is observational, so cause and effect are not fully established, but the direction of the claim is well supported by the available evidence.

Several large population studies show that regular coffee consumption is associated with a lower risk of dementia, but these are observational associations, not proven causal relationships. The claim states that 200 to 400 milligrams of caffeine produces a 'significant reduction', but that specific range and that strong conclusion go beyond what the available evidence supports. Moreover, the indications of a protective effect of caffeine against dementia are intriguing, but not yet strong enough to justify definitive claims.

Research confirms that the glymphatic system actively clears waste products from the brain during sleep, with deep sleep playing the most important role. There is also consistent evidence that poor sleep quality is associated with a higher risk of dementia. However, the claim that sleeping on your side specifically promotes glymphatic clearance goes beyond what the research actually establishes: whether your sleeping position is a determining factor in this process has not been demonstrated. Moreover, a link between improved sleep and genuinely slowing the progression of dementia in humans through targeted interventions has yet to be proven.

Research shows that spermidine is one of the best-supported candidates for stimulating autophagy, and that it occurs naturally in food and in your body. The claim that it 'activates' autophagy is correct in terms of direction, but the role of spermidine as an intermediate step has not yet been fully demonstrated in large human studies. Whether specific foods such as wheat germ and cheese measurably increase autophagy in the human body via spermidine is therefore also not yet firmly established.

Research does indeed show a link between accelerated brain aging and a higher risk of neurodegenerative diseases such as Alzheimer's. Observational studies indicate, for example, that a biologically older brain more than triples the risk of Alzheimer's. However, the specific figure of an 80% higher risk cannot be found in the available research, and the claim suggests more certainty than current science supports.

Research does indeed show that people differ greatly in how their organs age, and that in some individuals one organ stands out clearly. One source even mentions 'nearly one in five people' in that context, which supports the direction of the claim. However, that figure comes from observational research and the precise threshold of 'significantly faster' is not sharply defined, so the claim is somewhat more categorical than the evidence warrants.

The contribution of glycation to wrinkle formation and arterial ageing is well supported biologically: AGEs damage collagen, elastin and blood vessels, and the mechanism underlying skin ageing is plausible. The evidence for glycation's role in atherosclerotic plaque is less direct; the LDL- and apoB-driven plaque process is well described, but glycation's specific contribution to it is less firmly established in the research. The claim is therefore broadly correct, but the strength of the evidence differs for each component and the precise magnitude of each effect has not yet been determined.

There are tentative early indications that a ketogenic diet, through ketones, may be beneficial for people with memory problems, but the studies are small and not conclusive. The leap to specific anti-inflammatory effects on the brain and a proven benefit in Alzheimer's disease goes beyond what current research in humans can firmly establish. For a concrete verdict on Alzheimer's disease, large-scale, independent trials are still lacking.

Research shows that fine particulate matter is consistently associated with poorer cognitive performance and possibly faster memory decline, but whether this represents a truly causal effect has not yet been proven. The MIND diet is associated with less cognitive decline, but the only large controlled trial does not confirm this benefit. A specific protective effect of the MIND diet against the structural brain damage caused by fine particulate matter, such as brain shrinkage and white matter loss, has not been demonstrated in the research; the claim therefore goes beyond what the evidence supports.

Research consistently shows that air pollution, and fine particulate matter in particular, is associated with an increased risk of heart and lung disease, and that cleaner air demonstrably saves lives. The evidence for this is robust. The link with cancer is somewhat more nuanced: chronic inflammation, a mechanism that fine particulate matter can trigger, is a recognised risk factor for certain types of cancer, but the evidence largely comes from observational studies. The claim that fine particulate matter is causally linked to cancer therefore goes a step further than what current research conclusively demonstrates.

Research clearly confirms that air pollution costs millions of people their lives every year and that the damage to health is serious and robustly demonstrated. However, the specific claims that it is the second leading cause of death in the world and that it accounts for more than 8 million deaths per year are not supported by those exact figures in the available research. The direction is correct: air pollution is one of the largest preventable causes of death worldwide, but that precise ranking and that specific number cannot be firmly established on the basis of the current evidence.

Research shows that HIIT leads to greater fitness gains than regular cardio in cardiac patients, but whether this consistently holds true for healthy individuals as well cannot be established unambiguously from the available studies. The claim that both low-intensity cardio and HIIT increase VO2 max is correct in its direction, but the assertion that HIIT always produces greater short-term gains goes beyond what the evidence unambiguously supports. Moreover, the advantage of HIIT does not apply to all groups: in a certain form of heart failure, for example, it offers no benefit over regular cardio.

Research shows that a higher VO2 max is strongly associated with a longer lifespan and a lower risk of dying from cardiovascular disease. The direction of the claim is therefore correct. What the research does not confirm is that a specific value such as 50 represents a clear threshold below which 'considerable benefits' begin: the relationship appears to be continuous, with more always being better. Furthermore, whether VO2 max itself is the cause or primarily a measure of an active lifestyle has not yet been fully established.

Research clearly confirms that declining oestrogen levels during menopause are associated with greater fat accumulation in the abdominal area (visceral fat) and a worsening body composition. This link is well supported. However, the specific mechanism by which oestrogen suppresses appetite and actively directs fat to subcutaneous tissues, and by which a decline reverses this exactly, goes beyond what available research can establish with certainty: the shift towards abdominal fat is well documented, but the precise role of appetite suppression in this process cannot be firmly established.

Research shows that four or more sauna sessions per week are associated with greater health benefits, including a lower risk of cardiovascular disease and premature death, and that this association is dose-dependent. However, the specific percentages in the claim (63 percent reduction in sudden cardiac death and 40 percent reduction in overall mortality) do not emerge from the research and therefore cannot be confirmed. Moreover, the research emphasises that it is purely observational and that a causal relationship has not been established. The claim presents the figures as established fact, whereas the reality is more nuanced.

Research shows that insulin resistance is already measurable through elevated fasting insulin while blood sugar is still completely normal. Standard blood sugar tests respond too late to pick up this early signal. This supports the claim that fasting insulin rises before changes in fasting blood sugar become visible. However, the exact size of that time difference is not expressed in concrete years in the research.

Research into GLP-1 medications shows that a quarter of the weight lost consists of muscle and other non-fat tissue. This pattern is consistent with what is known from aggressive dieting as well: alongside fat, you also lose muscle mass. Strength training is the most well-supported way to limit this, and without it you face a greater risk of muscle loss. The claim therefore accurately reflects the current state of the evidence.

The recommendation of 1 gram per pound of body weight per day amounts to approximately 2.2 grams per kilogram per day. Research indicates that for maintaining and building muscle after the age of forty, an intake of 1.2 to 1.6 grams per kilogram per day is well supported, and up to 1.6 to 2.4 grams per kilogram when losing weight. The amount in the claim is therefore considerably higher than what the evidence recommends. Furthermore, research shows that strength training is at least as important as protein intake itself, something the claim does not mention at all.

Large-scale research consistently shows that low grip strength is associated with a higher risk of premature death, and that association is robustly supported. The direction of the claim is therefore correct. However, the specific figure of a 16 percent increase in risk per 10 to 11 pounds decrease in grip strength cannot be firmly established based on the available research. Moreover, this concerns an association, not a proven cause: grip strength reflects your overall muscular health and is not a direct cause of earlier death.

Research does indeed show that chronically short sleep is associated with an increased risk of high blood pressure, and this link has been found consistently in large populations. Sleeping too long is also associated with cardiovascular risks in population studies. However, the precise figure of 'up to 40% increased risk' and the exact upper threshold of 10 hours cannot be firmly established on the basis of the available research, and a fully proven causal relationship has yet to be demonstrated.

Several large population studies consistently show that eating more fibre is associated with a lower risk of colorectal cancer, and that association is well supported by biological explanations. The direction of the claim is therefore correct. However, the specific figure of a 10% reduction in risk per 10 grams of additional fibre per day cannot be firmly established on the basis of available research, and the precise amount of 10 grams as a threshold value is equally unsupported. The claim is therefore more specific than the evidence justifies.

That NAD+ declines with age has been consistently established in humans and animals. However, the claim goes further by stating that the decline amounts to exactly 10 to 20 percent and that NADH rises proportionally: neither of these specific claims is supported by the available research. Furthermore, the decline in NAD+ is related to increased breakdown and reduced production, not necessarily to a proportional rise in NADH.

Both caloric restriction and rapamycin convincingly and repeatedly extend lifespan in animal studies, including across multiple species. However, the claim that this has been 'convincingly demonstrated' across four categories of eukaryotes goes beyond what the available research supports: in humans, a lifespan-extending effect has not yet been proven for either intervention. Moreover, the delineation of exactly four eukaryotic categories is not reflected in the available evidence. The direction of the claim holds for animal models, but the claim is too categorical for the full spectrum.

Research shows that post-meal blood sugar spikes are associated with an increased cardiovascular risk, even well before the threshold for diabetes. The link with oxidative stress and the suppression of nitric oxide production in the arteries fits into this broader picture, but the available studies do not directly and causally confirm this mechanism in people without diabetes. The direction of the claim is plausible, but the specific biological mechanisms mentioned cannot be firmly established on the basis of current evidence.

Research confirms that the glymphatic system is active during sleep and that deep sleep plays the most important role in removing metabolic waste products. The claim is therefore broadly correct. However, the mechanism of expanding spaces around brain blood vessels is a more specific claim that goes beyond what available research in humans has unambiguously established; the precise workings have not yet been fully proven.

Research does indeed show a striking association between very frequent sauna use (four to seven times a week) and a lower risk of dementia, but the claim presents this as an established fact. The evidence currently comes from a single observational study conducted in Finnish men, which means that a causal relationship has not been demonstrated. Furthermore, the findings have not yet been confirmed in women or other populations, and randomised trials in humans are lacking.

Large observational studies do indeed show that short but vigorous bursts of physical activity spread throughout the day are associated with a substantially lower risk of cancer, cardiovascular disease and premature death. The direction of the claim is therefore correct, but the specific figures of 40% and 48 to 49% cannot be firmly established on the basis of the available research. Moreover, this is observational research, which means it cannot yet be said with certainty that the activity bursts themselves are the cause of the lower mortality.

Research shows that one year of aerobic exercise in older adults reverses 1 to 2 years of age-related brain shrinkage, as demonstrated in a randomised study. The claim is therefore broadly correct. However, the specific figure of 2% hippocampal growth cannot be firmly established on the basis of the available evidence, and the overall support for the claim is considered limited. The direction of the claim is right, but that specific number warrants scepticism.

Several studies suggest that older adults need more protein than the standard guideline of 0.8 grams per kilogram per day, due to a reduced sensitivity to protein. For healthy older adults, 1.0 to 1.2 grams per kilogram per day is a reasonably well-supported lower threshold for counteracting age-related muscle loss. The evidence for this is of moderate strength, but the direction is consistent. Combining this with strength training makes the effect considerably greater.

Research consistently shows that regular exercise is linked to a lower risk of colorectal cancer, and that falls within a broader range of 10 to 42 percent risk reduction across multiple types of cancer. The specific figure of 29 percent for colorectal cancer is not firmly established in the available evidence, so the direction is correct but that precise percentage cannot be substantiated. The protective effect of physical activity on bowel health is biologically well explained, in part through a beneficial effect on the gut microbiome.

Research shows that fasting can activate AMPK and that this triggers processes such as fat burning. However, the claim states that mitochondria therefore burn fatty acids "preferentially" as fuel, which goes a step further than what the available evidence supports. The picture is also more nuanced: prolonged fasting actually did not activate AMPK in human muscle tissue, and the effects on mitochondria come largely from animal and cell studies. The general direction is correct, but the claim is more categorical than the available evidence justifies.

Research shows that GrimAge, a specific epigenetic clock, predicts mortality better than chronological age alone. The claim therefore points in the right direction, but is formulated too broadly: not all epigenetic clocks perform equally well, and they do not work equally well in every cell type. Moreover, the evidence is associative, meaning that a lower epigenetic age does not automatically mean that you will also live longer.

Research shows that newer epigenetic clocks such as PhenoAge and GrimAge are more strongly associated with health and life expectancy than calendar age, and that they are currently the best-supported method for measuring biological ageing. As for telomere length, a commercial blood test is difficult to translate into concrete health advice, which makes it relatively less useful. However, the two methods are not directly compared in terms of accuracy in predicting chronological age, so that specific point of comparison cannot be firmly established based on the available evidence.

Research shows that fasting can reduce inflammation markers and indirectly benefit the immune system, but a true 'reset' of the immune system has not been convincingly demonstrated. No evidence was found for a specific 72-hour fasting period activating stem cells. The claim therefore goes far beyond what the available evidence supports.

Observational research shows that four or more sauna sessions per week are associated with the greatest cardiovascular health benefits and a lower risk of premature death, and that association is dose-dependent. However, the claim goes beyond the evidence on two points: a specific temperature of 79°C is not identified in the research as a threshold value, nor is a minimum duration of 20 minutes per session. Furthermore, the studies are exclusively observational, meaning no causal relationship has been established, and the evidence applies largely to men.

Research suggests that daily multivitamins do appear to offer some protection for memory in older adults, with an effect equivalent to roughly three fewer years of decline. However, the claim states 'approximately 2 years', which differs from the figure that emerges from the studies. Moreover, the evidence comes from several related studies within the same research programme, and independent confirmation is still lacking, so the conclusion is not as clear-cut as the claim implies. For other aspects of cognition and brain ageing more broadly, the evidence is limited or absent.

Research shows that intermittent fasting does produce demonstrable benefits, such as improvements in insulin sensitivity and insulin resistance, and that early time-restricted eating can achieve this effect even without weight loss. The claim therefore goes too far: there are situations in which fasting appears to offer something extra beyond simply eating less. At the same time, studies on the fasting-mimicking diet confirm that, for weight loss and metabolic improvement, both strategies are comparable, which partly supports the core of the claim. The evidence is based on small and short-term studies, however, so the question of whether the benefits of intermittent fasting are structurally greater than those of ordinary calorie restriction has not yet been definitively answered.

Research shows that a higher VO2 max is strongly associated with greater longevity and lower mortality from cardiovascular disease and cancer, and that the evidence for this is consistent and compelling. However, the claim that VO2 max is the strongest predictor goes beyond what the studies actually state: grip strength and genetics are also cited as serious predictors, without any ranking between them. Furthermore, VO2 max is likely more of an indicator of an active lifestyle than an independent cause of a longer life.

Research shows that there are indications that omega-3 slows biological ageing, but these indications are explicitly preliminary and contradictory. The claim is too categorical: it specifies a dose of 1 gram, targets people over 70, and refers to epigenetic ageing, while the available evidence does not support that level of detail. The direction cannot be ruled out, but the certainty and specificity of the claim go beyond what the available evidence allows.

Research shows the opposite: that NAD+ declines with age has been consistently demonstrated in both humans and animals. The mechanisms behind this decline, such as the increase of pro-inflammatory cells that actively break down NAD+, are reasonably well understood. The claim that the amount of NAD in cells does not decrease significantly is therefore directly contradicted by the available research.

Research shows that the core of the claim is correct: older adults actually need more protein than the standard guideline recommends, and too little protein leads to weaker muscles and bones and a higher risk of falls. This does indeed argue against protein restriction in older adults. However, regarding mTOR inhibition in older adults specifically, the available evidence only shows that it extends lifespan in mice, with no proven interventions for humans yet. The claim presents mTOR inhibition in older adults as a demonstrated problem for muscle maintenance, but this goes beyond what the available evidence supports.

Research shows that epigenetic clocks can predict biological aging and are linked to a greater risk of serious diseases, including conditions that arise later in life. However, the claim is more specific: it names cognitive decline, physical frailty, and the progression of Alzheimer's and Parkinson's disease explicitly, whereas the available literature does not specifically mention these conditions. Moreover, studies emphasize that the associations are correlational and that the clocks are not yet a clinical decision-making tool, which tempers the certainty implied by the claim.

Research shows that higher epigenetic age scores are linked to a greater risk of serious illness and death, but the specific figures of 8 to 15 percent per 5 years of aging acceleration have not been demonstrated in the available literature. The direction of the claim is therefore correct, but the precise percentages cannot be confirmed or refuted on the basis of the available research. In addition, the associations are correlational and large long-term studies are still lacking, which means that such specific estimates should be interpreted with caution.

Multiple studies consistently show that creatine in people over sixty, combined with strength training, improves muscle strength and muscle mass, which is relevant to sarcopenia. For bone density, however, the evidence is more mixed: strength training itself measurably increases bone density, but research does not support the idea that creatine makes an additional contribution to this. The claim is therefore partly correct, but the effect on bone density appears to be attributable to the training rather than to creatine as a supplement.

Research shows that a confirmed testosterone deficiency is associated with health risks, and that treatment can be beneficial for men with a confirmed deficiency. However, the second part of the claim goes too far: large studies such as TRAVERSE show that heart attacks do not occur more frequently with supplementation, but there are real risks of atrial fibrillation and pulmonary embolism. The claim that this treatment reduces the risk of cardiovascular disease is therefore not supported, and the benefits moreover explicitly do not apply to men whose testosterone decline is caused solely by ageing or excess weight.

Research shows that greater muscle mass increases your ability to clear blood sugar and that this is the most concrete hormonal effect of muscle mass. The link with insulin sensitivity is therefore correct. However, the claim goes somewhat further than what the evidence firmly establishes: the specific mechanism of glycogen storage in muscles is not described in the literature reviewed, and the evidence for the effect on insulin sensitivity is reasonably strong rather than conclusively proven as a cause.

Research shows that intermittent fasting has positive effects on, for example, insulin levels, weight and gut flora, but those benefits are far from equal for everyone. In healthy individuals, the evidence is thinner than in people with obesity or a metabolic disorder, and most studies are small and short-term. The claim that a fasting period of at least 12 hours produces clear health benefits therefore goes further than what current research broadly supports.

Research shows that both too little and very long sleep are associated with more illness and a higher risk of death, which supports the direction of the claim. However, the specific threshold of "more than 8 to 8.5 hours" is not defined that precisely in the literature reviewed: 8 hours is mentioned as a comfortable upper limit, without an exact figure for when long sleep becomes risky. The claim is therefore broadly correct, but the precise threshold goes beyond what the studies actually support.

Research shows that berberine measurably lowers blood sugar, which is consistent with the claim. However, the claim suggests that berberine does so effectively and without reservation, whereas the EFSA has been unable to establish a safe intake level due to indications of DNA and liver damage. In addition, berberine has strong interactions with medications, making its use in practice risky. The blood sugar-lowering effect is therefore real, but the word "effectively" creates an overly positive and incomplete picture.

This is correct and less widely known than its male equivalent. During REM sleep, women experience increased blood flow to the genitals in the same cycles as men, several times per night. This has been established through measurements in sleep laboratories.

Strength training demonstrably reduces depressive symptoms, and a large network analysis from 2024 found that exercise performs comparably to antidepressants in mild to moderate depression. 'Comparable' is therefore defensible, but 'greater than' cannot be substantiated: direct comparisons are scarce and the studies vary considerably in design.

Daily tadalafil at 5 milligrams is an approved treatment for urinary symptoms caused by an enlarged prostate, so the drug genuinely does something there. However, the reasoning offered here -- improved prostate blood flow and cerebral vasodilation as grounds for healthy men over forty to consider it -- goes well beyond the evidence. This is a prescription medication with side effects, not a general remedy for healthy men.

Well supported: randomised studies and follow-up analyses show that a cold bath immediately after strength training blunts muscle growth and part of the strength gains. Anyone training to build muscle is better off scheduling cold exposure several hours after the workout or on rest days.

This figure comes almost word for word from a randomised study conducted in the heavily polluted city of Qidong, China: a drink containing sulforaphane precursors increased benzene excretion by approximately 61 percent, from the very first day. One caveat: this is a single line of research, carried out in a specific environment.

For muscle growth, this is correct: meta-analyses show that training light to near muscular failure produces comparable muscle growth to training heavy. For maximal strength, it does not hold: heavier training consistently comes out ahead. The strength part of the claim therefore goes too far.

It is true that drinking patterns matter: heavy drinking in a single evening causes acute damage and increases the risk of alcoholic hepatitis. However, the liver research does not point in one direction: a large Danish cohort study found that daily drinking actually raised the risk of cirrhosis more than drinking on just a few days per week. The comparison is therefore less clear-cut for the liver than the claim suggests.

For cancer, there is indeed no safe lower limit and ethanol is a proven carcinogen; since 2023 the World Health Organization has stated that no safe level exists. However, 'no benefit at any dose' remains controversial: some large analyses find a small cardiovascular benefit from light drinking in older adults, while genetic studies cast doubt on this. Science has not yet reached a conclusion here.

CT studies do indeed show that greater muscle mass and higher muscle density around the chest and upper back are associated with fewer heart attacks and lower mortality, even in people with vascular plaque. However, this is observational research: it has not been proven that the muscles are the cause. Muscle mass is also an indicator of fitness and overall health in a broader sense.

This is consistent with animal research: in fruit flies, the effect of rapamycin depends strongly on the composition of their diet, and with some diets the drug does not extend lifespan or even has a detrimental effect. That said, this tells us something about fruit flies, not about humans.

A large 2023 American population study found exactly this association: people who ate one meal a day had higher mortality from all causes and from cardiovascular disease. The claim is also carefully worded as an association. One caveat: this is observational research, so a causal relationship has not been established.

Large randomised trials, including the 2023 TRAVERSE study, found no increased risk of prostate cancer in men with low testosterone levels during testosterone therapy. That part holds up. The claim that the therapy does not worsen existing prostate cancer goes further than the research supports: those studies followed screened men without active cancer, and in men with prostate cancer the evidence is limited to small case series.

Research shows that fermented dairy products such as yoghurt and kefir do indeed have the strongest clinical evidence for a positive effect on the diversity of gut bacteria and inflammatory markers. However, that evidence comes mainly from smaller studies and does not automatically apply to all fermented dairy products. The claim is therefore largely correct for yoghurt, but is slightly too categorical because the evidence is still limited and the effects can vary by product and by person.

Multiple studies show that creatine can improve muscle strength and muscle mass in older adults, which supports the direction of the claim. However, the evidence is strongest when creatine is combined with resistance training; without that combination, the effects are less clear. The claim presents an increase in lean muscle mass as an established fact, but that goes somewhat beyond what the research, which is of moderate quality, justifies.

Research shows that resveratrol has no proven effect on ageing in humans yet, and some clinical trials, such as those on brain ageing, produced negative results. Nevertheless, the claim is too categorical: the research is not concluded, but limited. Animal and laboratory studies do show interesting effects, and the conclusion is more that evidence in humans is lacking than that the opposite has been definitively proven.

Our answer on epigenetic reprogramming confirms that animal and cell culture studies show that ageing patterns can be reversed, which supports the direction of the claim. Research on retinal nerve cells in animal models fits within that broader picture. Nevertheless, the claim goes further than the available evidence justifies: evidence in humans is entirely lacking, and the biggest unresolved problem remains safety, as excessive reprogramming increases the risk of tumour formation. The claim sounds more definitive than the current state of research allows.

It is fair to say that the menstrual cycle affects far more than reproduction alone, and it is also true that women were long underrepresented in research. However, 'virtually every organ system' is a stronger claim than what has actually been measured: there is clear evidence for effects on sleep, mood, body temperature and immune responses, but for many other organs the question simply has not been studied. The point is valid, but its scope has been overstated.

Same source and same limitation as the previous one: a snapshot from a population survey in which blood values and sleep complaints were measured at the same time. The percentage is genuinely calculated, but it says nothing about what happens when you start taking vitamin C supplements.

Both are correct. A ten-to-fifteen-minute walk after a meal demonstrably lowers the blood sugar peak, and this has been measured in multiple studies. Cooling cooked starch produces resistant starch that the small intestine does not digest, and a review of 36 randomised studies confirms the lower peak. Both effects are modest, but real.

The first part is well supported: higher protein intake goes hand in hand with better muscle preservation, especially in older adults and when combined with strength training. The second part is contested. The relationship between protein intake and mortality varies considerably depending on the source: research points to more favourable outcomes for plant protein than for animal protein, and the picture differs between middle age and old age.

That a severely carbohydrate-restricted diet substantially lowers triglycerides and reduces liver fat has been observed in several short-term studies, and halving of triglycerides is not uncommon in that context. The studies are small, last a few months, and say nothing about long-term adherence or what happens afterwards.

This is supported by the strongest evidence in this series: a randomised study found that better adherence to a Mediterranean diet was associated with a lower estimated biological age based on DNA methylation, measured over eighteen months. What a slowdown in such a clock actually means for health or lifespan remains an open question; it is a measure, not an outcome.

A systematic review with meta-analysis does find this association, so the claim is accurately summarised. However, it remains an association: people who eat a Mediterranean diet also tend to exercise more, smoke less and have a higher income, all of which are likewise associated with telomere length. Moreover, telomere length in white blood cells is an unreliable measure that varies considerably between measurements.

There are trials in which a Mediterranean diet lowered markers of oxidative damage. These are short-term studies measuring intermediate outcomes in blood and urine, not studies demonstrating actual DNA damage or the prevention of disease. The direction of effect is consistent; its long-term significance remains unknown.

Broken heart syndrome is real and is known as takotsubo cardiomyopathy. Following acute emotional or physical stress, the left ventricle can change shape within hours and pump far less effectively, producing a picture that resembles a heart attack even though the coronary arteries are unobstructed. It usually resolves within weeks, but it can take a serious course.

The order of magnitude is roughly right: a widely cited overview of many studies found that people with strong social ties are considerably more likely to survive the study period. That is worded differently from the claim here, and this remains observational research in which illness itself can also lead to isolation.

This is well supported. Morning light is the strongest time cue for the biological clock, and studies show that early exposure improves the ability to fall asleep and overall sleep quality. It works best with daylight outdoors, which is many times brighter than indoor lighting.

This is a genuine debate within the field, and there are studies pointing in this direction: fitness is a strong predictor of mortality, even independently of weight and metabolic values. However, more recent and larger research adds nuance: being fit does not fully compensate for poor metabolic health. As an absolute statement it goes too far; as an encouragement to exercise regardless of your weight it is well-founded.

That exercise raises BDNF has been measured in humans and is one of the best-supported links between physical activity and the brain. The step towards neurogenesis is less firmly established, because whether adult humans generate new brain cells remains a matter of debate.

This comes from a real 2013 study that caused a great stir: during sleep, the space between brain cells increased by about 60 percent and waste was flushed out more quickly. However, the research was conducted in mice. In humans, the brain's waste-clearing system has been visualised, but that precise percentage has not been measured.

This is exactly what the research concludes. In the UK Biobank, with more than three thousand deaths over seven years, the regularity of sleep was a stronger predictor of mortality than the number of hours slept. Going to bed and waking up at the same time every day therefore matters more than the exact duration. It remains observational research.

The direction is correct and there is genuine research on this: in a Japanese cohort of seven hundred older adults, people who slept with light in the bedroom developed diabetes nearly four times as often as people who slept in the dark. That is a far larger difference than the 53 to 67 percent mentioned here, so those figures come from somewhere else. Moreover, this is observational research in older adults with nineteen new cases, making it a small study.

The idea that cooling the sleep environment improves sleep is plausible and is being investigated. However, the specific difference between men and women mentioned here, deep sleep in one group and REM sleep in the other, is not something I have been able to find in the literature. Sex differences of this kind require large studies, and those do not exist on this point.

It has been demonstrated that apigenin acts on the site in the GABA system where sleep medications also work, but this has been shown in test-tube and animal studies. 'Calming without sedation' is a marketing phrase: the dose at which it calms without causing drowsiness has not been established in humans, and the amounts used in those studies are far higher than what you can get from chamomile.

Deep sleep does decrease with age, that is true, and more so in men than in women. But 'almost completely lost' by the age of 45 is not what measurements show: in sleep research, middle-aged men still have perfectly normal deep sleep, just less than they had in their twenties. The decline is gradual and there is no age at which it suddenly tips over.

In cohort studies, dietary patterns rich in flavonoids are associated with lower rates of cardiovascular disease, and there are indications pointing in the same direction for dementia. However, it is nearly impossible to rule out that the overall lifestyle, rather than the flavonoids themselves, is responsible. Moreover, trials using isolated flavonoids as supplements deliver far more modest results than the cohort research suggests.

Population studies suggest that people who eat a lot of garlic and onions develop certain cancers and cardiovascular diseases less often. However, this is observational research, and people who eat a lot of garlic often have different dietary habits in general. Trials in which garlic was given as an intervention show, at best, modest effects on blood pressure and cholesterol.

This is an estimate by the World Health Organization, produced using a mathematical model, not an actual count. Such models rely on assumptions about intake per country and on the relationship between trans fats and heart disease. That industrial trans fats are harmful and that eliminating them saves lives is not in dispute; the precise number is.

It is well established that fasting and eating less activate the cell's cleanup processes, and there are review articles on the subject. The link to a longer lifespan comes from animal research, where caloric restriction extends lifespan in yeasts, worms, flies and rodents. This has not been demonstrated in humans, and the studies that do exist look at intermediate markers rather than actual longevity.

Both effects have been observed in animal research: the removal of damaged mitochondria and the formation of new ones. This has not been demonstrated in humans, as that would require taking muscle or brain tissue samples before and after. It is a plausible mechanism, but there is no human evidence.

It has been established that ketones affect the balance between inhibitory and excitatory signalling substances in the brain, and this is the prevailing explanation for why the diet works in epilepsy. The evidence comes almost entirely from animal and laboratory research; in humans, these substances cannot be measured directly in the brain.

Individual studies on fibre supplementation and waist circumference show modest results, but I was unable to find a convincing comprehensive analysis specifically on visceral fat. Visceral fat is also difficult to measure: it requires a scan, and many studies use waist circumference as a proxy, which is not the same thing.

The link between a sense of purpose and a longer life is well supported: in a large American cohort of people over fifty, those with little sense of purpose were more than twice as likely to die during the study period. However, 'the most important psychological predictor' implies a ranking, which would require directly comparing purpose with factors such as depression, loneliness, and optimism within the same model. That has not been done.

There is a randomized study in which mindfulness training was associated with lower IL-6 levels and changes in brain connectivity. At the same time, other studies found no effect on IL-6, and a study involving brief online meditation found no change in immune markers whatsoever. The specific protocol of five minutes over 28 days is not what has been tested.

The direction is correct: fiber slows gastric emptying, dampens blood sugar spikes, and promotes satiety. However, it depends strongly on which type of fiber. Randomized studies show that some fibers increase satiety without affecting blood sugar, and vice versa. The threshold of 25 grams is a general dietary guideline, not a measured tipping point above which these effects kick in.

That interval training increases growth hormone release has been genuinely measured; the effect is so reliable that it is even used as a test for growth hormone deficiency. Two caveats, though. Seventy percent of VO2 max is not a high intensity but rather solid endurance work. And the leap from higher growth hormone levels to faster fat burning is greater than it sounds: that peak is short-lived and its contribution to daily fat use is small.

There is research showing this, but in mice. In those studies, white adipose tissue does indeed shift towards brown fat under the influence of fasting, partly via the gut microbiome. In humans, brown fat is far scarcer and harder to measure, and it has not been shown that fasting activates it in us as well.

'Resetting the metabolism' is not something measurable. There is no switch that flips and no default state to return to. What going without food for a full day does do is draw on glycogen stores and increase fat burning, but those effects are gone again the following day.

This sounds logical and is an appealing idea, but I could find no research to support it. That the brain is more receptive to change during and after physical exertion has been described. That this therefore causes rumination to become more deeply ingrained when you follow gloomy news while exercising is an inference that no one has put to the test.

Two separate things are being conflated here. That aerobic exercise enlarges the hippocampus and improves memory has been demonstrated in humans. Whether adults produce new brain cells every day is, in fact, one of the most hotly debated questions in the field: two leading studies published in the same year reached opposite conclusions about whether this happens in adults at all. 'Every day' is therefore a far more categorical claim than the research supports.

There is evidence that people with stronger social bonds have lower inflammatory markers, and this has been measured on multiple occasions. However, the direction of the relationship cannot be established: people who feel ill and inflamed also tend to withdraw. That social contact itself reduces inflammation is plausible, but not proven.

The association is real and substantial: loneliness and social isolation are linked to a significantly higher risk of premature death. However, the comparison with fifteen cigarettes is merely a rhetorical device that researchers themselves have criticised. The figure comes from a conversion of effect sizes that are not comparable, and there is an analysis that sets out precisely this problem. Take the message seriously -- just not the number literally.

This is well supported. A randomised study in older adults found that hippocampal volume increased after a year of aerobic training, and memory improved along with it. The effect is modest and applies primarily to aerobic exercise of a certain duration -- a short stroll does not count.

This is the wrong way round. Light entering the eyes suppresses melatonin production -- an effect that has been measured in a dose-dependent manner, with blue light having the strongest suppressive effect. What is correct is the underlying idea: plenty of daylight during the day synchronises your biological clock, which allows melatonin to kick in at the right time in the evening. But that happens via the clock as an intermediary, not through direct stimulation of melatonin production.

That the body adapts to higher carbon dioxide levels through practising breath-holding is plausible and has been observed in divers. Systemic vasodilation, however, is an oversimplification: during breath-holding, activity in the sympathetic nervous system also rises, causing blood vessels in the arms and legs to contract while those in the brain dilate. The body does both at the same time, in different places.

That carbon dioxide dilates blood vessels is correct and well documented, particularly in the brain: at higher CO2 levels, blood flow there increases measurably. However, the reversal of the claim goes too far. Nitric oxide is the substance through which the vessel wall itself regulates blood flow, a role established by Nobel Prize-winning research. These are two distinct mechanisms, not competitors for first place.

That the body responds to oxygen deprivation with adaptations in the mitochondria is well established from altitude and exercise research. The leap to a lower biological age is an entirely different matter: it would require measuring an ageing clock before and after, in a controlled study design, and that research does not exist. The first part is physiology; the second is a promise.

That oestrogen influences the biological clock in the brain is plausible and there are indications to support this, primarily from animal research. How significant that influence is in humans, and whether it explains the sleep complaints seen during the menopause, has not been established.

There is a genuine link between oestrogen and the cholinergic system; this has been described in review articles and in primate research, and it is one of the explanations being seriously investigated. 'Directly linked' is too categorical. Memory complaints during the menopause are also associated with poor sleep, hot flushes and mood, and research has been unable to meaningfully disentangle these factors from one another.

It is plausible that poor sleep impairs muscle building, and there is a study that measured lower muscle protein synthesis under sleep restriction. A systematic review of seventeen studies does nuance the picture, however: a single sleepless night has little effect on strength, whereas multiple nights of short sleep do reduce force output during multi-joint exercises. The studies are small and of moderate quality.

There is a meta-analysis that found an increase of roughly this magnitude in older adults following omega-3 supplementation. However, the results of the various meta-analyses diverge, and a network analysis on sarcopenia places omega-3 clearly behind strength training and protein. As a standalone intervention, the effect is small and inconsistent.

It is well established that creatine produces additional lean mass gains during strength training, and multiple meta-analyses confirm this effect. However, the precise figure of 1.4 kilograms is more definitive than the literature warrants: it varies depending on the meta-analysis, the duration of the study, and the dosing protocol. Moreover, part of that gain consists of water retained in muscle cells rather than contractile tissue.

This finding comes from a meta-analysis of 49 studies involving 1,863 participants on protein supplementation during strength training. It found that the gains level off at around 1.6 grams per kilogram of body weight per day; the margin of uncertainty extended to well over two grams, so eating more is not harmful -- it simply provides no additional benefit.

This is indeed what the research shows: the amount of androgen receptor in the muscle itself is associated with how much muscle someone gains from strength training, whereas blood hormone levels do not show that relationship. The studies involved are small, conducted in men, and report correlations of around 0.6, meaning androgen receptor density explains part of the variation but not all of it.

Correct, and it actually happens faster than fourteen days. After just one week of bed rest in healthy young people, clear muscle loss has been measured alongside reduced insulin sensitivity. At two weeks, the effect is greater. This is also why hospitals nowadays get patients up and moving as quickly as possible.

That 174 percent comes from a real study: high-intensity strength training in ninety-year-olds, published in 1990. It did involve ten highly frail nursing home residents who started from an extremely low baseline, and when that is the case, tripling one's strength is easier to achieve than for someone who already trains. The fact that substantial gains are still possible at an advanced age has since been confirmed multiple times.

That older adults respond less well to protein is real and has a name: anabolic resistance. It has been described in review articles and partly explains why older adults need more protein. The precise figures of 30 to 50 percent at exactly 10 grams come from small mechanistic studies using muscle biopsies, often involving only a handful of participants. The direction is correct; the sharpness of the numbers is not.

Remarkably precise, because this comes from a randomised study by Stanford. People who ate fermented foods for ten weeks developed a more diverse microbiome and showed a decrease in nineteen inflammatory proteins. The group that increased their fibre intake did not see that effect. It is one of the few solid findings in microbiome research.

Correct. Before menopause, oestrogen directs fat more towards the hips and thighs and less towards the abdominal cavity and the liver. After menopause that shifts, and with it the risk of fatty liver disease rises. It is one of the most striking metabolic differences between men and women.

Correct, and it is an important warning. Anyone who already has a fatty liver combined with obesity, high blood pressure, or diabetes faces a far greater risk of serious liver damage from moderate drinking than someone without that combination. The two factors reinforce each other, meaning moderate drinking is by no means safe in that situation.

True, and this is one of the most thoroughly studied differences between sugars. Fructose is processed almost entirely in the liver, where it strongly stimulates fat production, far more so than glucose. This is precisely why soft drinks and fruit juice place a greater burden on the liver than the same number of calories from starch.

This comes from studies in which participants were followed for several years, and those studies did indeed show that people who gained muscle mass were more likely to recover from their fatty liver disease. However, observational research cannot separate cause and effect: people who exercise more usually also change their diet, weight, and alcohol consumption. That muscle mass plays a role is plausible; a fourfold increase in odds is a figure drawn from a single study.

True, and that figure has been revised sharply upward in recent years. Systematic reviews consistently find that around thirty to forty percent of adults worldwide are affected, making fatty liver disease the most common liver condition. The vast majority of those people are unaware of it, as it causes no symptoms for a long time.

It is plausible that refined sugar has a stronger effect on the reward system than sugar in whole fruit, and this is consistent with what we know about absorption rates. However, the idea of 'bypassing natural self-control mechanisms' assumes a system that has not been demonstrated in this way, and food addiction is not recognised as a diagnosis.

This figure is repeated everywhere, but it is a rough estimate. What is true is that a large proportion of your immune cells are found in and around your gut, in the lymphatic tissue along the intestinal wall. Seventy or eighty percent is a rule of thumb for that, not a measurement. More important than the percentage is that your gut and your immune system are in constant dialogue with each other.

Correct, and this is the finding from a large review study. Half an hour to an hour of strength training per week goes hand in hand with a ten to twenty percent lower risk of death, cardiovascular disease and cancer. Notably, more than an hour per week did not yield any additional benefit in that same study.

Correct, and this has been measured precisely. In a study of older adults with elevated blood sugar, three short walks of a quarter of an hour after meals performed at least as well as a single three-quarter-hour walk, and even better after the evening meal. The timing matters more than the total duration.

The study exists and is large: in tens of thousands of people wearing a wrist tracker, a regular sleep schedule turned out to be more strongly associated with mortality risk than sleep duration itself. That is a striking and useful finding. However, the range of 20 to 48 percent comes from a single study, and irregular sleep is linked to shift work, illness, and poverty.

Correct, and this is one of the best-known findings from the long-running American Nurses' Health Study. Five habits combined -- not smoking, maintaining a healthy weight, exercising, drinking in moderation, and eating well -- were associated with more than twelve extra years of life expectancy at age fifty. It remains observational research, but its scale and duration make it compelling.

There is no evidence whatsoever for hair loss; that is determined by genetics and hormones, and pornography use plays no role in it. For testosterone, the picture is more or less the opposite of what is claimed: short-term fluctuations say little, and no lasting effect has been demonstrated. That some people feel less desire for sex with a partner is a real phenomenon, but that is a matter of behaviour and habituation, not a hormonal problem.

That keeping your phone out of the bedroom helps is plausible, and there is research suggesting that less screen time before sleep leads to falling asleep more easily. But fifty percent better sleep is a figure without a source: sleep quality is not measured in percentages, and no study comes anywhere close to such a conclusion.

The first part is correct: processing makes food absorb more quickly, causing sugar and fat to enter the bloodstream sooner and at higher levels. The leap to addiction potential is an interpretation. The speed of absorption may explain why you feel hungry again sooner, but that is not the same as addiction.

This finding comes from a single study in which the brain responded more strongly to the combination of sugar and fat than to either one alone, which is a striking result. It is a small brain-imaging study that has never been replicated on a larger scale. Plausible, but not yet an established mechanism.

The association has been found using questionnaires that measure addictive eating behaviour, and these consistently point to ultra-processed food. Whether this can actually be called an addiction is disputed among researchers, however: there is no recognised diagnosis, and the questionnaire is derived from one designed for drug use.

Essentially correct, and by now broadly supported. Review studies link ultra-processed food to higher rates of cardiovascular disease, type 2 diabetes and premature death. The research remains observational, but the pattern is consistent, and one randomised trial shows that people spontaneously eat more of it.

This refers to a well-known study in which older adults who did a year of aerobic training ended up with a slightly larger memory centre, by around two percent. That finding is real, but later and larger studies did not consistently replicate the effect on volume. That exercise is good for your brain is well established; growth of the hippocampus is less certain.

Correct, and this has been well studied in humans. Regular cold exposure activates brown adipose tissue, which burns energy to generate heat, and triggers the production of new energy-generating structures within cells. What is less certain is whether this leads to noticeable weight loss or a longer life.

Correct in essence, and the evidence is stronger than for most lifestyle recommendations. Large Finnish population studies found significantly fewer cases of cardiovascular disease among people who used the sauna four to seven times a week compared to those who went once a week. One caveat: the research is observational, and people who sauna frequently tend to be healthier and more affluent in general.

Correct. Nano-hydroxyapatite is the same mineral that makes up your enamel, and it fills in early demineralization. In comparative research, it performs as well as fluoride against incipient cavities. In Japan, it has been used this way for decades.

Correct, and this is one of the most useful things you can know about blood sugar. A contracting muscle draws glucose from your blood through its own pathway, with no need for insulin. That is why exercising after a meal works so directly.

There are small studies on electromagnetic mats for pain and sleep, but they are small, rarely blinded, and often funded by the manufacturer. Moreover, the sense of relaxation people report after lying still on a mat for twenty minutes is difficult to separate from the effect of simply lying still.

There are a few small studies in which plaque thickness in the carotid artery decreased, but they are small, short-term and almost all from the same region. For a substance that acts as a blood thinner, that is far too little evidence, particularly when used alongside existing medication. A promising direction, but no proven effect.

The first part is correct: taking NMN demonstrably raises the amount of NAD in the blood, and this has been measured in multiple studies. What follows from that is far less clear. The studies on blood lipids and blood pressure are small, short-term and inconsistent in their findings. Moreover, NMN has not been approved as a food supplement in the EU.

This is exactly where resveratrol research hit a wall. In 2010, researchers showed that the measured activation was a measurement artefact: it only appeared because a fluorescent label had been attached to the test protein, and disappeared as soon as the experiment was run with the actual protein. The claim that resveratrol directly activates this enzyme is therefore not tenable.

This has been found in mice: a diet high in these amino acids shortened their lifespan, even without the animals eating more overall. The proportions involved are extreme and unattainable through a normal diet, and the question has never been studied in humans. For people looking to preserve muscle mass in later life, the evidence actually points in the opposite direction.

In laboratory animals, restricting food intake demonstrably extends life, that much is established. But the debate centres precisely on whether the eating window matters or whether it is simply the reduction in calories that counts. Recent mouse research suggests that timing does play a role, while other work shows that eating less is the main factor. Claiming this holds 'regardless of the details' is too categorical.

In mice, this has actually happened: researchers restored vision in animals with damaged optic nerves by activating three of these factors, and that was a remarkable result. But it involved a single tissue, in an animal, under controlled conditions. There is no basis yet for the general claim that ageing in tissues can be reversed, and it has not been attempted in humans.

This is one of the most exciting research directions at the moment, and the general finding points in the right direction: in large patient databases, diabetic patients taking GLP-1 medications develop dementia less often. However, this is observational research, not a trial, and that is precisely where a key problem arises: those who receive these medications are often better treated and more closely monitored. The randomised trials needed to settle the question are still ongoing, and the first results are expected within a few years.

There is research showing that the relationship between long-term blood sugar levels and cognitive decline extends below the diabetes threshold, without a clear cut-off point. That is a genuine and interesting observation. But precisely for that reason, there is no tipping point at 5.8 percent; that figure suggests a threshold that the research does not support.

Type 2 diabetes demonstrably increases the risk of dementia, but the pooled estimate from review studies puts it at roughly one and a half to two times the baseline risk. A threefold increase is the upper end of what a single study has ever found, and presenting that as the figure makes the risk appear greater than it is. The underlying point still stands: your blood sugar matters for your brain.

Correct: roughly two in three people with Alzheimer's are women. However, the explanation that usually goes with this figure is missing here: women live longer on average, and age is by far the greatest risk factor. Whether something specifically female also plays a role -- for instance related to menopause -- is being investigated but has not been established.

Abdominal fat in middle age is associated with a higher risk of dementia later in life -- this has been found repeatedly in population studies. That said, calling it a strong risk factor is an overstatement: the association is modest and likely runs mostly through blood pressure, glucose metabolism, and inflammation. It is not a standalone cause.

This refers to a well-known study in which older adults showed a slightly larger memory centre after a year of aerobic training, around two percent, which amounts to reversing one to two years of ageing. That result is real. Later and larger studies did not consistently find that effect on volume alone. That exercise is good for your brain is well established; that it measurably grows your hippocampus is less certain.

The fourteen factors are correct and come from the 2024 Lancet Commission review. However, more is being made of this than the data actually show. The commission calculated that around 45 percent of all dementia cases are theoretically linked to those factors at the population level, and only if every single factor were completely eliminated. That is not the same as an individual halving their own risk. Working on those factors is worthwhile, but this promise goes further than the research supports.

Correct, and this is one of the most important things people need to know about these new drugs. In the large trials of lecanemab and donanemab, roughly one in five to one in four participants developed swelling or small bleeds in the brain, visible on a scan. Usually without symptoms, but not always: serious cases and deaths have also been reported. That is why close monitoring with scans is an essential part of the treatment.

There is a genuine link between type 2 diabetes and Parkinson's disease, found in multiple population studies. However, the pooled estimate from systematic reviews is around twenty to forty percent increased risk, not 85 percent. That high figure comes from a single study and is presented here as though it represents the general finding.

Correct, and this is the figure used by the Alzheimer's Association: approximately eleven percent of people over 65 have dementia. The figures for the Netherlands are in the same ballpark. It is worth noting, however, that the rate rises sharply with age: below 75 it is a few percent, while above 85 it is a multiple of that.

The figure is higher than the commonly used estimate. The Alzheimer's Association, which is cited later in the same episode for the number among people aged 65 and over, puts the share for the group aged 85 and older at around one third. Forty to fifty percent does appear in the literature, but it usually refers to all forms of dementia combined, or to estimates that include people who have the disease in their brains without showing any symptoms.

There is a real link: zinc is needed to make vitamin A available from the liver, so a zinc deficiency does reduce the effectiveness of vitamin A. However, 'only effective if' is too absolute, and dry eyes caused by a vitamin A deficiency are rare in this part of the world. In most cases the cause lies elsewhere, in the tear film.

Correct, and it is a well-known phenomenon during the transition. Ketones and uric acid share partly the same excretion pathway in the kidney, so as long as ketone levels are high, more uric acid is retained in the blood. It subsides after a few weeks. Anyone with gout should take this into account.

True. Potassium lowers blood pressure and helps relax the vessel walls, and population studies show that a higher potassium intake is associated with fewer strokes. Through food, this is almost always safe. Potassium supplements are not: in people with reduced kidney function or those taking certain blood pressure medications, they can disrupt heart rhythm.

It is true, and there is a clear explanation, that statins lower the level of coenzyme Q10 in your blood: they inhibit the same pathway the body uses to produce Q10. What does not follow from this is that it causes symptoms. Studies in which people with muscle complaints were given Q10 showed no convincing improvement.

True, and it is one of the best-supported associations in sleep medicine. In sleep apnea, your oxygen levels drop dozens of times per night, which drives up blood pressure and puts strain on the blood vessels. Treatment with a CPAP mask measurably reduces those risk factors.

Two things are being confused here. What is true is that a large proportion of your immune cells are located in and around your gut. The microbiome is something different: it refers to the bacteria that live there. They communicate with your immune system and influence it, but they are not your immune system.

Almost all research into these eye drops comes from their inventor, in small studies that have never been replicated by independent researchers. A systematic review found insufficient evidence that they slow or reverse cataracts. Moreover, cataracts are easily treated with surgery, and delaying that treatment on the basis of eye drops costs you your vision.

Hs-CRP is the most widely used measure and does carry real meaning, particularly regarding your risk of cardiovascular disease. That said, 'reliable' is a strong word: the value shoots up with any infection, is associated with excess weight and smoking, and fluctuates considerably from week to week. A single measurement tells you very little.

In animal studies this is clear: fasting activates the cell's housekeeping processes. In humans the picture is more mixed. Time-restricted eating improves inflammatory markers in some studies but not in others, and it is difficult to separate this effect from the fact that people in such studies typically also eat less overall.

That omega-3 reduces inflammation, including in the brain, is reasonably well supported. The claim that it keeps bacterial particles from crossing the intestinal wall goes beyond what the research shows: there is some indication of this from animal studies, but not from human studies.

Oats do indeed contain a protein that resembles gluten, and in a small group of people with coeliac disease this triggers a reaction. For most people, oats are well tolerated. The bigger practical problem is cross-contamination during processing, not the protein itself.

Correct on both counts. Strength training improves insulin sensitivity even without weight loss, and it reduces fat around the organs. The latter often happens faster than what the scales show.

Correct. Abdominal fat around the organs is not passive storage but active tissue that releases hormones and inflammatory substances. That is precisely why fat around the organs weighs more heavily on your health than fat under the skin.

Correct, this is well-researched cell biology. Damaged mitochondria leak more reactive oxygen species, and these activate precisely that inflammatory complex. It is one of the pathways through which ageing and inflammation reinforce each other.

The association is robust and the direction is plausible. There is even a randomised trial in which people eating ultra-processed food spontaneously ate more and gained weight. For the inflammation itself, however, the evidence is weaker: it comes mainly from population studies, where lifestyle and excess weight cannot be disentangled.

Correct, and this has been firmly established in the laboratory. Healthy people who sleep less for several nights already show higher inflammatory markers and respond less well to insulin. Both return to normal once sleep is restored.